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Abstract
Utilization of nanoparticle heating for controlled release application was proposed and its
feasibility was explored. The proposed method was formulated by realizing that biomolecule -
nanoparticle conjugation is heat sensitive and both their dimensions are in the same length scale.
This exploration centered on showing the proof of concept that conjugated biomolecules can be
released from the nanoparticle surface in a controlled manner by heating the nanoparticles via
external energy sources. The selectivity of the multiple releases was also investigated.
Two mechanisms of nanoparticle heating were explored. The AC magnetic heating of magnetic
nanoparticles has limitation due to its low-power energy delivered to nanoparticles. The
irradiation of femtosecond laser pulses on the absorbing gold nanorods provides the answer to
this limitation due to the very high-power of energy delivery through these ultrashort pulses.
We developed gold nanorod surface customization technique to enable DNA - nanorod
conjugation, thus turning gold nanorods into nanoscale carriers. Pulsed laser excitation in
resonance with their absorption peaks can heat and melt the nanorods. This is exploitable for
controlling the release of DNA oligonucleotides conjugated onto the nanorod surface. Nanorods
with different aspect ratios absorb light at different wavelengths and thus can be excited
independently. We have successfully demonstrated the selective releases of two distinct DNA
oligonucleotides, where each is released from a different type of nanorod. This was
accomplished by the laser excitation at two different wavelengths corresponding to both of the
nanorods' absorption peaks. The releases were very selective, efficient, and externally tunable by
adjusting the laser fluence. The released DNA oligos were still functional. This concept is
expandable to beyond two species. Its thiol conjugation chemistry is versatile and capable of
high loading. With these advantageous factors, this proof of concept of selective multiple
triggered releases from gold nanorods have a great potential as a new strategy for multiple
controlled released application.
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Thesis Supervisor: Paula T Hammond
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Chapter 1
Introduction
1.1. Motivation
Nature has managed to produce multitude biological molecules that can perform
numerous tasks with high degree of precision and efficiency. This diversity of
biomolecules typically composes a very complex biological system with its robust multi-
layered control system.' In an effort to harness the engineering of nature, many scientists
and engineers are working not only to characterize this biological system but also to
develop a method for direct manipulation of the biomolecules. 2-4 This is important
because in any attempt to understand the natural function of any biomolecule, one
typically performs elimination processes at multiple levels. Therefore it is understandable
that there is always the need for more methods to manipulate or control these
biomolecules.
On the other hand, nanoscale material (nanoparticles) has gained a lot of interest
in the past decades, due to their unique tunability of their optical, magnetic, electrical,
thermal, and chemical properties. 5-9 These nanoparticles (NPs) are typically about the
same length scale of the biomolecules, such as proteins and DNA. Soon enough
researchers started to explore the means to interface between the NPs and the
biomolecules.' 0' 11 This leads to many fundamental studies attempting to understand the
nature of these biomolecules using the nanoparticles as their tools.12 , 13 These
nanoparticles can be tuned appropriately for different purposes. They can be synthesized
small enough to be used as probes for understanding the structure of biomolecules. They
can also be synthesized to be large particles that can carry a high number of biomolecules
on their surface.
Acknowledging that there is always the need for more ways to control
biomolecules, we are motivated to develop a better and simpler method to control
biomolecules by utilizing nanoparticles. Realizing that most biomolecules are heat
sensitive in term of their structures, activities, and conjugations (with NP); we proposed
an idea of controlling the biomolecules by increasing their local temperatures. Since both
biomolecule and NP are typically in the same length scale, we then proposed the
utilization of NP as the local heat sources. The main hypothesis is basically exploring the
energy delivery mechanism from external sources to increase the temperature of NP
which is conjugated to or incorporated with biomolecules. In turn this will elevate the
temperature of the biomolecule; which then alter its structure, activity, or even their
conjugation with NP itself. So if we can control the delivery of energy to heat up the NP,
then we can control the biomolecules directly with NP. Therefore this method will not
rely on physiological environment as control mechanism. 14 16 We are interested in one of
the simplest form of control of biomolecules; controlled release of the conjugated
biomolecules from their NP counterpart.
The next stage of the hypothesis is utilizing different NPs to control the releases
of different biomolecules. This will show the selectivity and multiplicity of this method.
More specifically we are motivated by the potential application of our method for
enhancing the efficacy of combination therapy. Combination therapy or the use of
multiple drugs has been sought for improving treatment efficacy of diseases such as
malaria,1 7 cancer, 18 and HIV.19 Though proven to be effective, the differences in the
chemical properties (such as molecular weight, solubility) and pharmacokinetics of the
components in a drug mixture can create challenges for loading, delivery, and release of
multiple drugs.20 Even if a pre-determined synergistic ratio is encapsulated in a carrier,
this ratio may not be maintained at a target upon delivery or during release. Typically, the
timing of the release of each species is crucial for drug efficacy, as has been observed for
tumor treatment.18 Therefore, for effective combination therapy, release rates of each
drug must be controlled independently. Current solutions involve complex systems such
as polymer multilayer 2 1 or sophisticated bioMEMS implants.22' 23 Nanoscale carriers have
gained attraction, but achieving different release windows for each drug in a mixture
requires engineering intricate architectures.' 8 Extending all of these strategies beyond two
species or even changing the order of release is problematical. Clearly, an effective
method to externally control release of each species independently and actively would
ultimately lead to optimization of combination therapies. Therefore, in this thesis we like
to show that our proposed method can be potentially effective for this particular
application; by showing the proof of concept of our idea in utilizing multiple types of
NPs to independently control the release of different biomolecules.
1.2. Objectives
In order to show the proof of concept of our hypothesis, we need to accomplish
four specific aims from our investigation:
1. Explore methods for delivering energy to the NP from external energy sources, in
order to heat up the NP.
2. Show the proof of concept that we can selectively heat different types of NPs.
3. Develop systems that incorporate NP and biomolecule (nano-bio systems)
4. Utilize these nano-bio systems to show that we can selectively release multiple
biomolecules via the selective heating of different types of NPs.
1.3. Strategies
We investigated two methods of delivering energy into the NPs from external
energy sources in order to elevate their temperature. They are alternating current (AC)
magnetic field heating of magnetic NPs and pulsed laser photothermal heating of gold
nanorods (NRs). The first mechanism typically utilizes the localized magnetic NPs in
human tissues (e.g. tumor tissue) to transfer energy from external AC-magnetic field into
heat. This heat will enable the destruction of malignant tissue where the particles are
localized. The study of magnetic fluid hyperthermia was started in 1957 by Gilchrist et
al.,24 utilizing micrometer magnetite particles. But, not until 1993, when A. Jordan et al.25
used single domain NPs, showed that NPs gave much superior heating than multi-domain
micrometer particles. We are interested in study the heating rate of different types of
magnetic NPs. The difference in the magnetic properties of different types of magnetic
NPs will govern their heating profiles. We hope to exploit the differences in their heating
profile for selective heating between two different magnetic NPs. In turn, we use this
selective heating for controlling the selective release of different biomolecules.
On the other hand, gold,26, 27 NPs have been exploited for both passive and active
targeted delivery. 28, 29 In the case of gold NPs, their surface chemistry has been proven to
be chemically versatile for loading biomolecules and optimizing physicochemical
parameters.26, 30 Gold nanorods (NRs) have also become attractive for biological
applications due to their optical properties. 3 1, 32 Pulsed laser excitation in resonance with
their longitudinal surface plasmon resonance (SPRong) can heat NRs locally to high
temperatures, 33 inducing melting. This triggered melting is exploitable for controlling the
release of biomolecules conjugated to the NRs. 34 Since SPRong is tunable by changing
NR aspect ratio (AR),6' 35 NRs with different ARs can be excited independently at
different wavelengths. If different NRs are conjugated to different molecules, this
strategy could be utilized for orthogonal triggered release of multiple species. Therefore
we hope to show that this strategy can also serve well to our hypothesis.
1.4. Thesis Outline
The investigation of AC magnetic field heating of different types of magnetic NPs
is presented in Chapter 2. In the following chapter (Chapter 3), we show our method of
loading magnetic NP and drug model into lipid vesicles. The NP-lipid vesicle system was
then used to study the feasibility of controlled release of the drug model via AC magnetic
field heating. This study and its limitation are presented in Chapter 4. This chapter also
discusses how the photothermal heating mechanism may overcome such limitation. In
Chapter 5 we show our synthetic capability of producing two different types of gold NRs.
We then show that they can be excited independently and thus selectively heated (and
melted) by exposure to femtosecond laser pulses at their corresponding absorption
wavelengths. This investigation is presented in Chapter 6. In Chapter 7 we show that we
can load different type of DNA oligonucleotide onto each type of gold NR (NR act as
nanoscale carrier). Therefore we can study the release selectivity of different DNA
oligonucleotides from two different types of gold NRs when they are selectively excited
(melted). This selectivity study is presented in Chapter 8. Finally the thesis concludes
with the discussion of our experimental results, the limitations and advantages of our
proposed method, and how it can potentially be useful for the proposed controlled release
application (Chapter 9). This chapter also includes some recommendations for further
studies.
Chapter 2
Magnetic Field Heating of
Nanoparticles
Magnetic nanoparticles (NPs) have been investigated for a variety of biomedical
applications. These applications range from magnetic separation of biomolecules,
magnetic carriers for drug delivery, magnetic resonance imaging (MRI) contrast
enhancement, to hyperthermia. Magnetic NPs have some unique properties which make
them very attractive for these applications. First, their sizes (from 10-100 nm) make them
much smaller than a cell (10-100 pm) or virus (20-450 nm), but close to a protein (5-50
nm) or a gene (2nm wide and 10-100 nm long).7 Due to their size and solubility, it
enables them to get closer to, tagged, labeled, or bound onto any of these biological
entities. Second, since they are magnetic and the ability of magnetic field to penetrate
into human tissue, therefore they can be remotely affected or controlled by external
magnetic field. Third, these particles can response resonantly to time-varying magnetic
field, which in turn, it enable the transfer of energy from the excited field to these
particles.
Hyperthermia utilizes all of the above attractive properties of magnetic NPs,
especially the third property. This application utilizes the localized magnetic NPs in
human tissues (e.g. tumor tissue) to transfer energy from external AC-magnetic field into
heat. This heat will enable the destruction of malignant tissue where the particles are
localized. This story of magnetic fluid hyperthermia already started in 1957 by Gilchrist
et al. 24, where they used AC magnetic field to heat up the micrometer magnetite particles
which have been injected into the subserosa of the intestine of dogs. Numerous other
researchers have followed up the investigation in this area. But, not until 1993, when A.
Jordan et al.25 used single domain NPs, showed that NPs gave much superior heating than
multi-domain micrometer particles even at lower field amplitudes.
2.1. Magnetic Fluid Hyperthermia
In order to appreciate and get a better picture on the idea of using localized
heating mechanism to kill malignant cell in tumor tissue, we need to go back and learn
about its history. The development of the concept started from the idea of using elevated
body temperature to cure illness and all the way to magnetic fluid hyperthermia. Off
course, this was also followed by evolving principle of the heating mechanism along the
way.
2.1.1 History of Hyperthermia
The history of hyperthermia dates back to around 3000 BC when the Egyptians
used a "fire drill" to burn away a tumor in the breast and in India people used steam bath
to cure variety of illness.3 In today's terminology, these practices of tissue destructions
at temperature of higher than 470C are called "thermoablation". The term of
"hyperthermia" it self is coined to an application of temperature increase in range of 41 to
460C onto malignant cells in cancer tissue. Nowadays, hyperthermia has replaced
thermoablation due to the undesired systemic side effects of thermoablation. The
compelling biological rationale of this hyperthermia concept is mainly on the differences
of vascular and blood flow system between tumor and normal tissues. Typical tumor
tissue has poor and disorganized vascular and blood flow system in comparison to normal
tissue. This deficiency has two implications. First, poor blood circulation in tumor tissue
means that it has poor heat dissipation if the tumor may become hotter. Second, it is
known that tissue with poor blood circulation will result in nutrient deficiency and lower
pH around that tissue region. Both of these implications make tumor cells viable to
killing by hyperthermia.36 The essential challenges for the hyperthermia application is
providing sufficient enough heat and it has to be localized around the tumor and leaving
the surrounding tissue unaffected.
There have been a numerous techniques in the history of hyperthermia, but they
mainly categorized into three techniques, whole body, regional and localized
hyperthermia. With whole body hyperthermia, thermal energy is introduced into the body
and maintained the temperature at 420 C for a few hours. This can be done by non-
invasive methods such as hot air, hot wax, infrared or radiofrequency radiation,
invasively by heating the blood extra-corporeally. Uniformity in temperature can be
achieved but the maximum permissible temperature is relatively low. With the regional
hyperthermia a large portion of your body (trunk or whole limbs) where the tumor
located, are heated either invasively or non-invasively. While with the localized
hyperthermia, only a smaller volume of the tissue local to the tumor is heated. Both
regional and localized hyperthermia can be performed invasively by the usage of non-
ionizing electromagnetic waves or ultrasound, or invasively by using interstitial implants
inserted into the body cavities. 36
2.1.2 Current Status of Magnetic Fluid Hyperthermia
The latest and current method in localized hyperthermia is involving the usage of
ferromagnetic or ferrimagnetic material confined within the treatment area and exposed
to external oscillating electromagnetic field. Instead of using electric (E-) field as for
most of the interstitial hyperthermia method, magnetic (H-) field dominant system is used
to inductively couple the energy to the lossy medium of the ferromagnetic particles.
These confined ferromagnetic particles dissipate energy from the applied H-field in the
form of energy through various kinds of energy loss mechanisms, such as eddy current
loss, hysteresis loss and relaxation losses, which will be discussed in details in the
following subsection. The first study of magnetic fluid hyperthermia (MFH) was
conducted by Gilchrist et al. in 1957.24 They injected micrometer size of magnetic
particles into the subserosa of dog intestine and observed a high concentration of
magnetite localized in particular lymph nodes near the injection site. Then they used an
excised lymph node containing 47mg of ferrite per gram of tissue, an AC H-field
intensity of 15 - 20 kA/m and frequency of 1 - 2 MHz. They observed a temperature
increase of 4.70C/min. Gilchrist et al. continued their work in this MFH method for the
next decade since his first reported study. The trends in their experiment setup are
decreasing frequency and increasing H-field amplitude, with their rationale of reducing
the heating of normal tissue.37' 38 In 1979, Gordon et al.39 for the first time used a narrow
distributed dextran magnetite to treat mammary tumor bearing rats. They used AC H-
field with frequency of 450 kHz, but unfortunately no field strength was given. In 1993,
A. Jordan et al.25 studied the comparison between large multidomain particles and single
domain particles in their potential for MFH using specific absorption rate (SAR) as a
quantitative measurement. SAR will be discussed in details in subsection 2.1.4. In the
same year, DCF Chan et al.40 discussed a method of colloidal magnetic iron oxide
synthesis and its superiority in SAR measurement. And in the past few years there is even
stronger surge of interests in using ferrofluids for the hyperthermic treatment of human
cancers.
2.1.3 Magnetic Field Heating Mechanism
Instead of reviewing all the heating mechanism for all type of hyperthermia
techniques, this subsection will only review the current technique (magnetic fluid
hyperthermia) which is relevant to this proposal. We know that the particles dissipate
energy from the applied H-field in the form of heat. The three known mechanisms of this
heat dissipation will be described in details in following subsections. Depending on their
material properties, NPs can utilize either one or any combination of those mechanisms.
1. Eddy-Current Loss
When we place a conductive (magnetic or non magnetic material) material in a
(AC or DC) magnetic field, the magnetic flux moves, the motion of magnetic lines
cutting across the conductor forces the free electrons in the conductor to move, producing
current. This is called induced current, because the process is an induction where there is
no physical connection between the source of magnetic field (e.g. magnet) and the
conductor.
When we place a conductive material in a varying magnetic field (AC magnetic
field), the currents are induced on the conductor, which flow in swirls or eddies within
the solid mass of the conductive material. These are called eddy currents. The heating due
to eddy currents is the same as the current flowing through a light bulb filament or an
electric resistance heater. Basically the current flow (1) through a resistance (R) and the
heating is simple 12R heating. M.T. Thompson41 discussed further details, complications
and theory to quantify this loss mechanism.
2. Hysteresis Loss
Hysteresis describes the phenomenon of the lagging behind of response of the
magnetic flux, B in a material when the applied magnetizing field (force), H is increased
or decreased, as shown in Figure 2.1. This phenomenon can be physically explained by
the magnetic domain wall motion and magnetic moment rotation which occur when a
magnetizing force is being applied. As the magnetizing force is decreased or change
direction these wall motion and moment rotation is not perfectly elastic or reversible,
meaning that they lags the increase or decrease of magnetizing force. This phenomenon
can be viewed as an internal friction. The work done by the magnetizing force against
this internal friction produces heat. This energy wasted in form of heat is called hysteresis
loss. Hyteresis loss can be measured by vibrating sample magnetometer (VSM) or
superconducting quantum interference device (SQUID). The hysteresis loss can be
estimated approximately in the case nearly rectangular hysteresis loop by
Phy = P y, fM, H (2.1)
where P, is a constant factor, f is the field frequency [Hz], M, is the saturation
magnetization [T], and H c is the coercivity [A/m]. Since coercivity depends on the
particle dimension,42 therefore the power loss Phy clearly depends on both frequency and
the dimension of the particles.
B Flux Density Saturation
Retentivity
Coercivity
Magnetizing Force
Saturation WI Flux DensityIn Opposite Direction 
-B In Opposite Direction
Figure 2.1. Hysteresis Loop, B-H curve as a response to alternating magnetizing force H.
3. Relaxation Losses
Superparamagnetics are magnetic particles which volumes are small enough that
the thermal energy is considerably larger enough to affect the magnetization of each
particle which results in random orientation of the magnetic moments of particles.
Therefore in the absence of an external field, these particles have no magnetization. In the
present of an applied magnetic field, we need to take into consideration the relaxation
time of the system due the thermal energy effects on the magnetization process. For our
frequency range of the applied AC magnetic field, there are two types of relaxations to be
considered:
1. Brownian Relaxation: With this Brownian mechanism, the magnetic moment
seems to be locked in the crystal axis of particle, therefore the entire particle
rotate in alignment with the direction of magnetic field. The Brownian relaxation
time constant is given by:43
87CqRj
TB =k (2.2)
kT
where: r= solvent viscosity [Pa-s], RH = hydrodynamic radius of the particle,
kB = boltzman's constant and T = temperature.
2. Noel Relaxation: at higher frequency, the Brownian motion is essentially frozen
out, the magnetic moment start to rotate within the particle. This second
mechanism is call N6el relaxation. The Neel relaxation time constant is given
by:44
KV
TN = r exp (2.3)
kT
where: zo= the natural gyromagnetic frequency (ro-10 9 s), K = anisotropy
constant [J/m3], and V = Volume of the particle.
These two mechanisms compete at certain frequency, while one will dominate over the
other at certain range of frequency. When both exist, the effective relaxation time will be:
ZNT Beff - (2.4)
ZN + TB
The power losses to one or both of these relaxation mechanisms can be calculated by:
45-47
(mHoeff )2
P 2 (2.5)
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where: m = the particle magnetic moment [J/T], H = the external magnetic field strength
[T] or [A/m], co = 27zf, and f = the frequency of the applied H-field [Hz]. This equation
clearly shows that the power losses depends the material properties (m), frequency
(o = 2f) and particle dimension (V = (4/3)zr3).
2.1.4 Specific Absorption Rate (SAR)
C.K. Chou4 8 first adopted the terminology of specific absorption rate (SAR),
which is commonly used in bioelectromagnetics research as a form to quantify the rate of
energy deposition in tissue, into the hyperthermia study. For the in vitro study of
magnetic fluid hyperthermia, SAR [J s-'kg-1] quantifies the amount of energy converted
by magnetic particles from H-field into heat per unit time and mass. The in vitro SAR of
magnetic fluid is usually determined from the time-dependent calorimetric measurement.
Figure 2.2 (a) shows the typical experiment setup of in vitro SAR measurement. The
SAR of magnetic fluid is usually determined by the "rate of temperature rise" method.
Figure 2.2 (b) shows the typical temperature profile of time-dependent SAR
measurement. It is determined by the initial linear temperature rise after switching on the
magnetic field:48
dTSAR = c - (2.6)
dt
where c= the specific heat capacity of the solution [J g-1' K-], and dT/dt= the
temperature increase per time [K/s]. The c-value of the solution is defined as the
weighted mean between the magnetic particles and the solvent (e.g. c of water = 4.118 J
g-1 K-'l).
As it is described earlier that there are a few mechanism to how magnetic particle
dissipates heat. The magnitudes of all of these mechanisms depend on frequency f,
magnetic field strength H, and a frequency-dependent characteristic constant of a
material k. Therefore the SAR values should also indicate their dependency on these
variables. Their dependency can be approximately described by:
SAR = kf"Hm  (2.7)
While most researchers 25' 48 reported in very much of agreement that the value of m equal
to 2, but n varies slightly. Jordan, A. et al.25 reported that n = 1, while Chan, D.C.F., et
al.48 reported that n varies from 1.1 to 1.5. In general, indeed the SAR values depend on
the frequency and amplitude of the applied AC H-field. The differences in the
dependency of SAR values on frequency may be due the differences in the experimental
setups (such as how good is the thermal insulation of the sample).
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Figure 2.2. (a) Experimental setup and (b) temperature profile of SAR Measurements.
2.2. Selective Heating of Multiple Nanoparticles
Magnetic NPs have been getting a lot of interests from the scientific community
due to their size- and material-dependent properties. As mentioned earlier in the
introduction, we propose to develop a method to independently address more than one
type of NP by selective magnetic field heating. We can accomplish this by studying the
NP heating dependence on the frequency of magnetic field by varying NPs' material and
(b)
T
size. First we need to conduct theoretical analyses for feasibility study. We then need
investigate the heating rate profile of NPs of different magnetic materials as a function of
frequency and determine if there are optimum heating rates for a narrow frequency range.
Furthermore, the dependencies on the amplitude of the applied H-field are also equally
important, and will also be investigated. SAR measurement discussed earlier is an ideal
tool for these experimental explorations.
2.2.1 Theoretical Exploration
We mainly interested in smaller superparamagnetic NPs because their sizes are in
the same order of magnitude with biomolecules such as DNA and proteins. The
relaxation losses (Equation 2.2 - 2.5) are the primary mechanism of magnetic heating of
the superparamagnetic NPs. The power loss equation (Equation 2.5) shows that
magnetic field heating is a function of the material, NP size, and the field characteristics.
We illustrate that tuning of all of these parameters is necessary to find conditions under
which multiple types of NPs can be heated independently.
In order to investigate the feasibility of our propose study, the dependence of the
power loss equation on these parameters is explored. The material dependence of power
losses is reflected by the parameter m and K in equation 2.5 and 2.3 respectively. For the
spinel ferrite MFe 20 4 (M = Fe, Co, Mn) NPs,49 the magnetic moment per particle, m
strongly depends on the type of transition metal ion, M2+ occupying the tetrahedral and
octahedral positions. The anisotropy constant, K highly depends on the type of crystal
structure and the degree of crystallinity of the NPs. Both m and K also have a strong
dependence on NP size. Therefore the material and size dependence of the power losses
are intertwined. Figure 2.3 shows a plot of equation 2.5 as a function of NP size for a
given field of 0.01 T and frequency of 3 MHz for CoFe20 4, Fe30 4, and y-Fe20 3, and
MnFe20 4. The heating shows strong size dependence for each of the materials, which
has been observed experimentally. 25
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Figure 2.3. Power loss equation as a function of nanoparticle size for a field of 0.01 T
and frequency of 3 MHz for CoFe20 4 (dashed line), Fe30 4, (solid line) and y-Fe203
(dotted line) and MnFe20 4 (points and line).
The frequency dependence of the magnetic field heating based on the power loss
equation is plotted in Figure 2.4 for 14 nm CoFe20 4 (dashed line), 15 nm Fe30 4 (solid
line), 15 nm y-Fe20 3 (dotted line), and 12 nm MnFe20 4 (points and line) with an
applied field of 0.01 T. The power dissipated by the NPs increases with frequency and
then plateaus at higher frequencies. This general shape has been observed experimentally
in the literature.25 50
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Figure 2.4. Power loss equation as a function of frequency at 0.01 T for 14 nm CoFe20 4
(dashed line), 15 nm Fe304 (solid line), 15 nm y-Fe 20 3 (dotted line), and 12 nm
MnFe20 4 (points and line).
Independent heating of these four types of NPs is possible if field strength H is
also tuned. Figure 2.5 shows the power loss equation where four different field strengths
are applied at different frequency ranges. 14 nm CoFe20 4 (dashed line) can be heated
preferentially over the 15 nm Fe30 4 (solid line), 15 nm y-Fe20 3 (dotted line), and 12 nm
MnFe20 4 (points and line) at any frequency below 20 kHz and at any field strength. 15
nm Fe30 4 can be heated selectively if one applies field strengths of 1 mT at a frequency
of 1 MHz. 15 nm y-Fe20 3 can be heated selectively if one applies field strengths of 0.35
mT at a frequency of 20 MHz. Finally, 12 nm MnFe20 4 can be heated preferentially at
frequencies above 100 MHz if the field strength is 0.13 mT. This shows that according to
the power loss equation, tuning the parameters of NP size, material, field frequency and
field strength, one can preferentially heat one type of NP over the others.
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Figure 2.5. Power loss equation as a function of field frequency and field strength for
14nm CoFe20 4 (dashed line), 15nm Fe30 4 (solid line), 15nm y-Fe 203 (dotted line), and
12nm MnFe20 4 (points and line).
2.2.2 Experimental Results
Magnetic Nanoparticles
We also tested this theoretical hypothesis experimentally. We performed magnetic
field heating study of two different types of NPs, iron oxide and magnetic Au/Fe NPs.
Aqueous Fe 30 4 NPs were purchased from FerroTec (Product name: EMG 705). The NPs
were at a volume fraction of 3.9% and used without modification. TEM imaging by
JEOL 2010 FEG Analytical Electron Microscope (Figure 2.6 (a)) confirmed that NPs
were well dispersed and not aggregated, with <d> = 12.5 nm + 3.4 nm (Figure 2.6 (a)).
Size analysis was done utilizing ImageJ.5'
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Fe/Au bimetallic NPs were synthesized in water by a simple modification 52 of a
standard synthesis for gold NPs.53 In brief, HAuC14 and FeCl3 were reduced in aqueous
solution simultaneously in the presence of citric acid, tannic acid, and sodium carbonate
at T = 500C to nucleate Au NPs doped with Fe. The NPs were functionalized with the
ligand bis(p-sulphonatophenyl) phenylphosphine dihydrate, dipotassium salt (BPS) by
ligand exchange. The NPs were purified from reagents and excess ligand by multiple
precipitations with NaCl and centrifugation. They were re-suspended in water and further
purified by agarose gel electrophoresis. Figure 2.7 (a) shows a TEM image of the sample
deposited from water solutions onto ultra thin holey carbon coated copper grids (Ted
Pella). The TEM image reveals that the NPs are well separated and not present in
aggregates. In addition, the NPs resulting from this synthesis are relatively monodisperse.
A distribution of <r> = 3.9+0.5 nm (histogram, Figure 2.7 (b)) was determined through
analysis of TEM images containing approximately 175 NPs. The Fe content of the NPs
was 1.8%, as measured by elemental analysis in STEM.
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Figure 2.7. (a) TEM of Fe/Au bimetallic NPs and (b) histogram of sizes, <d> = 7.8+0.7
nm.
Experimental Setup
The first challenge for performing SAR measurement is how to generate AC
magnetic field with strong enough amplitude to heat up the NPs and to characterize this
field. This subsection addresses these issues. A typical simple system to generate AC
magnetic field requires at least a signal generator, an amplifier, and an inductor coil, as
shown in Figure 2.8. As the current I flow through the copper wire of the coil, by
Ampere's law a uniform magnetic field inside the solenoid coil can be approximated to
be:41
NI
B - (as long as l >> d) (2.8)
where N = the number of turns of the coil, 1 = the length of the coil, and d = the diameter
of the coil.
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Figure 2.8. A typical system for generating AC magnetic field.
Coil Design
A handmade inductor coil can easily constructed using an insulated copper wire.
This copper wire usually graded by its diameter which will have a certain value of
resistivity, p [ohms/meter]. The coil's DC resistance is simply:
RDC = pL (2.9)
where L = the total length of copper wire used to construct the coil. There is also an
additional resistance due to the non-uniformity of magnetic field distribution in the wire
(skin effect) and the induction effect of the neighboring magnetic field of each wire turn
in the coil (proximity effect). This resistance value goes up with higher frequency, and
can be approximated by:54
(2.61x 10-7 VRAC (f )   (2.10)
where f = frequency [Hz], p, = relative resistivity (compared to copper = 1), and D=
wire diameter. The total resistance can be approximated by:54
R(f)= (RDC )2 + [RAC (f)]2 (2.11)
As current I flows through the coil, overcomes the total resistance R, there will be some
losses in form of heat. These losses are usually known as copper losses, and can be
calculated by:
P= I'2R (2.12)
As we want to selectively heat up the NPs by the magnetic field, we need to avoid
the heat propagation from the coil to the NP solution. Therefore we need to have a
mechanism to withdraw the heat from copper losses away from the sample inside the
coil. Figure 2.9 shows the schematic of our system to address this issue. This proposed
solution utilizes the circulating water bath to continuously withdraw the heat from copper
losses and some insulating layer to further isolate the sample.
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Figure 2.9. Water-cooled coil system to selectively deliver H-field to the sample.
RF Test Measurements
H-field Characterization.
To the best of our knowledge, there is not a commercial H-field probe to measure
magnetic field at wide range of high frequencies. However there are current probes that
are suitable for our purposes to measure the current flowing in the coil at high
frequencies. The current probe (Tektronix Inc.) that we used simply measures the
magnetic field around the current-carrying wire to back-calculated the current amplitude.
With a known current flow, we can then estimate the H-field strength.
RF-immune Temperature Probe.
Since the sample is placed inside the coil to get maximum H-field, therefore to
measure the temperature we need to place the probe inside the H-field environment.
Generally, thermocouples are made of metal, which will be affected by H-fields,
invalidating the temperature reading. Fortunately, there are non-metal fiber optic
temperature probes which are small in dimension and flexible. This is very advantageous
for our temperature (SAR) measurements. This probe (Luxtron Corp.) essentially utilizes
a fluorescent material with temperature dependent optical properties. This material is
placed at the tip inside the probe, which is in thermally equilibrium with the outside
temperature. Inside the probe there are also a bundle of optical fibers for excitation and
emission measurements of the fluorescent material. This probe was utilized for all the
SAR temperature measurements.
Typical Experimental Setup
The actual experimental setup combine the two concepts illustrated in Figure 2.8
and 2.9. It was similar to those used in the other literatures for hyperthermia evaluation.42'
50 Current was supplied to a water-cooled coil of 25 turns, inside of which the sample was
placed. Sample volume was typical around 100 il. The temperature of the sample was
measured as a function of time by a fluorescent temperature probe (Luxtron). Currents
were supplied by a signal generator (Hewlett Packard) amplified through a 100W
amplifier (Amplifier Research), in the frequency range of 100 kHz to 100 MHz. The field
strength was calculated by measuring the current using a high-frequency current probe
(Tektronix) and an oscilloscope (Agilent). Custom software (written in LabView)
controlled the application of the signal and also measured the field strength and
temperature. Due to the mismatch of the impedance, the current in the coil was obtained
by combining frequency dependence circuit simulations in PSPICE (Personal computer
Simulation Program with Integrated Circuits Emphasis) with the actual readings of the
current probe.
SAR Measurements - Results and Discussion
SAR Measurement is an ideal tool for studying the heating rate of NP solution at
certain range of frequency. We conducted a series of SAR measurement for two types of
NPs mentioned above, Fe 30 4 and Fe/Au NPs. They were suspended in water with
concentration of 1.19 mg/ml and 14 mg/ml for Fe 30 4 and Fe/Au NPs respectively.
Figure 2.10 shows the typical heating profile these NPs solutions when they are exposed
to AC magnetic field. An alternating magnetic field at given approximate field strengths
(green line) at frequency of 1 MHz and 40 MHz for Fe30 4 and Fe/Au NPs respectively,
were applied between t = 100 s and 400 s. Upon the application of the field, the
temperature of NP solution increased; while the control experiments without NPs in the
solution show no temperature increases (blue line). The SAR value of NP solution is
determined by the initial linear temperature rise of a fluid measured after switching on the
magnetic field (Equation 2.6). The initial slope of the temperature increase was typically
obtained from the temperature profile (such as in Figure 2.10) by fitting the rise to an
exponential function based on the analytical solution of the boundary value problem for
T(t) of the sample [20]. The estimated value of the initial slope was calculated by
differentiating the resulting exponential function with respect to time and solving at time
equal to the time when the field first turned on. The heat capacities (c) of the NP
solutions were approximated by using a weighted average of heat capacity of the NP
(CNp) and water (Cwater).
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Figure 2.10. SAR measurements. Upon the application of the magnetic field (green
line), the temperature of (a) Fe30 4 (brown line) and (b) Fe/Au (red line) nanoparticle
solution increased, while the controls (blue lines) stayed at room temperature.
The SAR value was measured and calculated for a given field strength and
frequency. Therefore, we conducted a series of SAR measurement at various field
strengths and frequencies to test our theoretical hypothesis mention earlier in this chapter.
Figure 2.11 shows the plots SAR values or power loss as a function of the applied
magnetic field strengths for both Fe 30 4 and Fe/Au NP solutions. SAR has been shown
empirically to be a function of field strength (H) to Hm and frequency (f) to f (Equation
2.7) where the values of m and n are experimentally determined. Figure 2.11 also shows
this dependence on field strength (brown square for Fe30 4 NPs and red square for
Fe/Au NPs) can be fitted to the mth order power-law curve. In the case of Fe30 4 NPs the
value of m -2 (black line); while for the Fe/Au NPs the value of m -2 at low field
strengths (blue line), but at higher field strengths, m - 3 (green line). Third-order power-
law H dependences are typical of Rayleigh losses.55 Previous work has shown that second
order losses are indicative of superparamagnetic samples and third order losses for
ferromagnetic samples.50 The phenomenon of switching from m = 2 to 3 field dependence
has been observed in magnetic hysteresis of magnetosomes 56 but this is not described by
the power loss equation, which only shows a square law field dependence. Since we also
observe this behavior, it suggests that hysteresis losses may play a role in the heating of
the Fe/Au NPs. Therefore, power losses alone cannot describe the field-dependent
behavior of these particles.
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Figure 2.11. Power loss as a function of field strength for (a) Fe30 4 (brown square) and
(b) Fe/Au (red square) nanoparticle solution. The plot was fitted to the m th order power-
law curve for both Fe 30 4 (black line) and (blue line and green line).
In order to assess our hypothesis and to compare to the theoretical assessments,
we performed SAR measurement at a range of frequencies (f). Figure 2.12 shows power
loss per particle as a function of field frequency for both Fe30 4 and Fe/Au NP. Both plots
seems to follow relaxation losses trends, where it is a square law dependent on frequency
at lower frequencies, but frequency independent above some threshold.46 This behavior is
similar to our theoretical assessment. The same have also been observed experimentally
for Fe30 4 NPs. 25 It should be noted that the frequency dependence at which SAR plateaus
is extremely sensitive to the value of the anisotropy constant used in the calculation. Thus
theoretical calculations can be used only as an approximation of the trends.
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Figure 2.12. SAR values or heating rate of Fe30 4 (brown square) and Fe/Au (red
square) nanoparticles as a function of frequency.
4x10 ~l x. -'3
o U 0.7 1x10 -- FeoS2x10 -.- -- Fe/AuI.ilxi0' 5o
0 7  -.- FeAx10u
1x10 - 1
0 2x10' 4x10' 6X10' 8x106  2x10 7 4x10 6x10 7 8x10 7 1x108
Frequency (f) [Hz] Frequency (f) [Hz]
(H=1000Alm) (H=1000Alm)
Figure 2.13. SAR values or heating rate of Fe30 4 (brown square) and Fe/Au (red
square) nanoparticles at (a) low and (b) high frequency ranges.
2.3. Summary
In summary, we have reviewed extensively the concept of magnetic heating of
nanoparticles and how we plan to exploit this for our hypothesis. We have also studied
the size and material dependence of magnetic field heating of nanoparticles. Independent
heating of multiple types of nanoparticles is theoretically possible by exploiting the size
and material dependence of the power loss equation. Preliminary results from
experiments on two different types of nanoparticles show that independent heating has
feasible potential.
Chapter 3
Loading Magnetic
Nanoparticles into Lipid
Vesicles
In the previous chapter we have shown the feasibility of selective heating of
multiple magnetic nanoparticles (NPs) both theoretically and experimentally. The end
goal of our hypothesis is to utilize this selective heating for potential selective multiple
controlled release application. In order to study the feasibility for this application, we
need to build system that can incorporate both the NPs and biomolecules and have the
mechanism to release the molecules when the NPs heat up. We proposed a system of
mixture of two different thermosensitive vesicles each contain different types of NPs and
molecules to be released (Figure 3.1). By appropriate tuning of the applied magnetic
field, we can selectively heat certain type of NPs, thus disrupts certain vesicle which then
release the contained molecules. We utilized lipid vesicles (liposomes) and fluorescent
dye as thermosensitive vesicles and the models for biomolecules respectively. In this
chapter we report a morphological study of NPs in large unilamellar lipid vesicles. Phase
behavior of this NP-lipid system was studied to maximize the loading of NPs into
vesicles.
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Figure 3.1. Schematic model of selective release of multiple dye molecules (blue and
green stars) due to selective heating of multiple nanoparticles (brown and red spheres);
Two thermosensitive lipid vesicles (gray vesicles) each contain different type of
nanoparticle and dye molecule.
3.1. Why Liposome - Nanoparticle System
Liposomes have attracted interest for drug delivery applications because of their
ability to encapsulate and release payloads. 57 Because their composition is similar to cell
membranes and their surface chemistry can be modified for specific targeting, they have
unique biological capabilities.'" For example, they have been used to target tumor sites
and release anti-cancer drugs. 59 Encapsulation of NPs in liposomes is desirable for
applications such as triggered heating by hyperthermia, drug delivery, 60-6 5 enhancing
MRI, 66 imaging by fluorescent NPs, 67 and photothermal therapy.68 Liposomes are self-
assembled vesicles of amphiphilic lipid molecules. The lipid bilayer which forms the
vesicles wall is temperature sensitive and can be "melted" at certain temperature, thus
induce leakage/release of the payload. This liposome phase transition temperature can be
tuned by adjusting length of the lipid molecules. This why liposome is the ideal system
for our purpose to study controlled release induced by magnetic heating of encapsulated
NPs (Figure 3.1)
Currently, numerous preparation methods of lipid vesicles exist.69'70
Encapsulation of hydrophilic moieties is achieved by introduction to the aqueous phase
so that they can be spontaneously captured inside the liposomes during vesicle formation.
Approaches that increase the internal liposome volume have been pursued for
encapsulation of large amounts of payloads. The reverse-phase evaporation method by
Szoka et al.71 has been successful in creating large unilamellar vesicles (LUV) with a
large internal aqueous space, and has been used to make liposomes that encapsulate
molecules, proteins, DNA,72 and NPs.67,73-75 The mechanism of encapsulation is
hypothesized to occur when lipid vesicles self-assemble from a collapsed gel-like state,
enclosing the payload into vesicles.
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For many applications of NP-encapsulated liposomes, high density encapsulation
is desirable. Hyperthermia and drug delivery both benefit from high NP loading. Also,
magnetic resonance contrast enhancement relies on NP clustering and requires that the
NPs be fairly close together, where inter-particle distances are on the order of only a few
NP diameters. For our hypothesis described earlier, it is also desirable to have high
loading of NP into liposomes in order to generate enough heat to disrupt the vesicle and
release the load. Unfortunately, it is generally difficult to achieve uniformly spherical
liposomes with high loading of NPs,73-75, 77-81 and often low yields result. Recently, Chen
et al.67 reported on average only 3 QDs per liposome of d-50-300 nm. Martina et al.82
reported -60 Fe20 3 NPs/100nm liposome. While liposome formation by itself is well
understood, phase diagrams have not been constructed in the case of an encapsulant with
significant volume fraction is present. It is expected that the presence of NPs, especially
at high concentrations, will appreciably affect liposome phase diagrams, such as for block
copolymers.8 3 Therefore, understanding NP-lipid morphologies is necessary to optimize
NP encapsulation.
We performed a systematic study of the phase behavior of di-palmitoyl
phosphatidylcholine (DPPC) with 12nm Fe30 4 NPs, with the goal of maximizing the NP
encapsulation in DPPC vesicles. TEM imaging was used to qualitatively analyze
resulting morphologies and quantify NP-loaded liposome size distribution. We are able to
synthesize liposomes that are densely packed with NPs. Varying lipid and NP
concentration results in different NP-lipid morphological structures. We find that high NP
concentrations perturb the phase diagram in such a way that it effectively increases the
concentration of the lipid. Key parameters for producing high yield NP loaded liposomes
are determined.
3.2. Liposome Preparation Method and
Characterization
Materials
Aqueous Fe30 4 NPs were purchased from FerroTec (product name: EMG 705).
The NPs were at a volume fraction of 3.9 % and used without modification except
dilution. TEM imaging (Figure 2.6 (a)) confirmed that NPs were well dispersed and not
aggregated, with <d>= 12.5 nm ± 3.4nm (Figure 2.6 (b)). Di-palmitoyl
phosphatidylcholine (DPPC) was purchased from Avanti Lipids. All other chemicals
were purchased from Sigma-Aldrich.
Liposome Preparation Method
To produce liposomes with large internal volume and thus potential for high
loading, we used a slightly modified version of the reverse evaporation method 71
(protocol in Figure 3.2). 20, 40, or 60 mg DPPC was dissolved in 12ml of a v:v = 1:1
mixture of chloroform and isopropyl ether in a 50 ml round-bottom-flask that was
cleaned using Avanti Procedure.84 This is referred to as the "organic solution" (panel 1).
1.5 ml of 3.9, 1.95, 0.98 or 0.39 vol% of Fe30 4 NP solution and 1.5 ml of 20mM calcein
at pH 7 were added into the organic solution (referred to as the "mixture," panel 2). Ar
(g) was bubbled through the mixture to remove any oxygen.
The mixture was sonicated in a bath sonicator at T = 500 C for 5 min to produce a
water-in-oil emulsion (Figure 3.2, panel 3). The mixture was cooled slowly and sat for
>30 min. Stability of the emulsion was confirmed before proceeding. The organic
solution was removed from the emulsion slowly using a rotary evaporator at T=500C
with P = -11 to -14 inHg for 2.5 hr (panel 4). At this point, most of the solvent had been
removed, forming a gel which adhered to the flask wall (panel 5). Note that the operating
temperature was well above the Tm of DPPC (41.5 0C). Other REV methods to prepare
DPPC vesicles69and magnetoliposomes 73 have used T = 20-25 oC and 42C respectively,
while others use T = 45-50C.67' 75.85 Here, sample repeatability was greatly improved by
operating at T = 50C, significantly higher than Tm of DPPC. Therefore, all data
presented on samples here had a preparation temperature of 500C.
The vacuum in the flask was broken and purified deionized water was added to
the gel (or continuous phase water, CPW86) to replenish any that was lost during
evaporation, or for further dilution to achieve certain final concentrations. The amount of
CPW varied from synthesis to synthesis, and may also depend on the evaporator setup.
Pressure was further reduced at increments of -1 inHg/5min until reaching P = -22inHg.
At this point the gel had completely collapsed, forming lipid vesicles (Figure 3.2, panel
6). This pressure was maintained for another 15 min to remove traces of solvent. The
resulting aqueous solution was allowed to sit undisturbed for at least 3 hrs before
deposition on a TEM grid for imaging.
Purification by centrifugation
To remove aggregates, the solution was first centrifuged at 100 g for 5 min and
the supernatant retained. The solution was then centrifuged at 200 g for 5 min to remove
un-encapsulated materials. The supernatant containing non-encapsulated NPs and calcein
was discarded, and the desired product in the precipitate was re-suspended in 20 mM
TES buffer solution (pH 7). Centrifugation was repeated twice, resulting in a purified
solution of NP-encapsulated liposome vesicles.
Imaging and Sizing
Samples were imaged by TEM (JEOL 2011). Samples were deposited on holey
carbon grids (Ted Pella) directly from solution. Images were taken at least within 3 days.
Size analysis was done by Image J.S'
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Figure 3.2. Method for NP encapsulation into lipid vesicles via REV method. Lines:
lipid, dark gray: organic solvent, light gray: water, circles: NPs, stars: calcein.
3.3. Results and Discussion
Concentration Effect
By varying the lipid and NP starting concentrations, and the amount of added
CPW, we studied the effect of lipid and NP concentration on resulting lipid/NP
morphology. There is a limit to increasing the lipid concentration, because too high of a
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lipid concentration will result in the inability of the gel (Figure 3.2, panel 5) to collapse
and form vesicles; this remains stuck to the flask wall and is not recoverable. In contrast,
starting lipid concentration must be high enough to produce a stable water-in-oil
emulsion (Figure 3.2, panel 3).
Figure 3.3 (a) shows the range of lipid and NP concentrations explored. Figure
3.3 (b)-(f) show images of the corresponding morphological features. The lipids are
unstained so dark areas in the image correspond to NPs. These images were taken of the
original solutions at least 3 hrs after preparation, without purification by centrifugation.
These morphologies are identical to those observed for the lipid-only system (Figure
3.4).87-89 At the highest NP concentration (-100 mg/ml, squares in Figure 3.3 (a)),
perforated bicelles are formed (Figure 3.3 (b)). The NPs are dispersed in the bicelle sheet
that has pores (resembling a slice of Swiss cheese). Some of these bicelle sheets contain
features of spherical lipid vesicles (resembling bubble wrap, Appendix A). A mixture of
both was commonly observed. Others have proposed the structural model of these
perforated bicelles (or perforated lamellar phase).87' 90-93
Phase behavior studies of lipid-only systems (Figure 3.4) find that spherical LUV
and multilamellar vesicles (MLV) are formed at low lipid concentrations, while the
perforated lamellar phase occurs at high concentrations.87-89 Clearly, the NP
concentration is high enough to affect the lipid phase diagram significantly, and changes
the resulting phases. For example, increasing NP concentration at a fixed lipid
concentration, the resulting morphology moves from HNLV to perforated lamellae. This
effect is similar to increasing lipid concentration in lipid-only systems. For example, we
can obtain the perforated bicelles phase at low lipid concentrations simply by increasing
the NP concentration. Interestingly, similar effects have been observed for lipids in the
presence of large molecular weight hyaluronan, indicating that introduction of large non-
lipid species can favor formation of lamellae. 94 Varying lipid concentration from 15-40
mg/ml has little effect on the resulting phase (squares in Figure 3.3 (a)).
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empty vesicles and NP-loaded vesicles (Figure 3.3 (d)). In the image, unloaded vesicles
appear as large empty circular structures. Finally, at [NP] = 12-13 mg/ml (circles, Figure
3.3 (a)) mostly spherical vesicles with high loading of NPs are formed (Figure 3.3 (e)),
or high density NP loaded vesicles (HNLV). Figure 3.5 shows a high resolution image of
a HNLV -200 nm in diameter, which contains a spherical mass of NPs at high density
(Figure 3.5 (a)). Resulting morphologies seem to be independent of lipid concentration
for [NP] >13 mg/ml.
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Figure 3.4. The phase diagram of typical phosphatidylcholine (PC) and PC+PG
(phosphatidylglycerol). Three phases are depicted and the phase transition temperature is
350 C. CI, is concentration of lipids. Reprinted with permission from the American
Chemical Society. 8 7
At lower NP concentrations (5-13 mg/ml), changing lipid concentration varies
vesicle loading and size (circles and stars in Figure 3.3 (a)). Lower lipid concentrations
yields smaller, low density NP loaded vesicles (LNLV) (Figure 3.3 (f)). At [lipid] = 21-
23 mg/ml the obtained morphology is predominantly HNLV (Figure 3.3 (e)) while at
[lipid] = 7-9 mg/ml it is predominantly LNLV (Figure 3.3 (f)). Figure 3.5 (b) shows a
higher resolution image of a LNLV -100 nm in diameter, which appears to have fewer
layers of NPs encapsulated. This could be due to the fact that at lower lipid
concentrations, only smaller vesicles can be formed on average.
Since it is desirable to produce high yield NP encapsulation into liposomes, the
predominantly HNLV sample (Figure 3.3 (e)) was purified by centrifugation to remove
un-encapsulated NPs (method and characterization, above). The resulting solution
contained only uniformly spherical HNLV with no free NPs (Figure 3.6 (a)). Size
distribution measured by TEM was d = 225 nm ± 67 nm (Figure 3.6 (b)).
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Figure 3.5. TEM Images of (a) high density NP loaded vesicles (HNLV) and (b) low
density NP loaded vesicles (LNLV)
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Figure 3.6. (a) TEM image and (b) size distribution of centrifuge-purified HNLV, <d> =
225 ± 67 nm, 388 HNLV sized.
Kinetic Effect
Incomplete vesicle formation has been observed in molecular dynamics
simulations, where incomplete closure of the vesicle results in a water pore in the
membrane. Because the bilayer vesicle is not sealed, the hydrophilic contents can spill
out.9 5 We observed instances of this phenomenon where vesicles which did not reach
complete closure, and NPs can be seen leaking out (Figure 3.7). This image is of the
same sample in Figure 3.3 (e) and Figure 3.6, except the aliquot was withdrawn within
30 min after liposome preparation, as opposed to >3 hrs. This agrees with studies of the
kinetic rate of micelle to vesicle transition of other lipid systems, which find that
timescales for growth of disk-like intermediate micelles to closed vesicles is typically
hours.96, 97 Dynamic light scattering experiments on egg lecithin suspensions after
sonication have shown that complete transformation from planar disks to closed vesicles
was observed after 3 hrs. 98
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Figure 3.7. (a) TEM image of predominantly HNLV solution sampled within 30min after
liposome preparation shows the majority of vesicles have incomplete closure; (b) High
resolution TEM images from (a) showing the incomplete vesicle closures where the NPs
spill out.
Other Effects
Centrifugation for long times (>10min) or at higher speed (>1000g) induced
vesicle fusion (Figure 3.8). Others have studied the fusion phenomenon of lipid vesicles
during storage which shows the apparent dependence on the duration of storage time and
temperature. 9
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Figure 3.8. (a) TEM image of HNLV solution after 1000g centrifuge purification shows
majority of HNLV fused with each other; (b) High resolution TEM images showing the
fused lipid bilayer of two HNLV.
3.4. Summary
In summary, the resulting morphology of a lipid/NP system is strongly dependent
on NP and lipid concentrations. This study has enabled the production of large spherical
lipid vesicles that encapsulate 12 nm Fe 30 4 NPs at high yield (HNLV). The presence of
NPs perturbs the phase diagram, with the effect of increasing the effective lipid
concentration. Key factors for HNLV formation include an operating temperature of
500C, higher than the lipid transition temperature. Sufficient time for complete vesicle
formation is necessary (-hrs). Future studies will assess liposome stability, finer size
control, and applicability for controlled-release.
Chapter 4
The Limitation of Magnetic
Field Heating
In the previous chapter we have shown our extensive study of resulting
morphologies of NP-lipid system. We have shown that we can tune the concentration of
both NPs and lipid to obtain the morphology of high density NP loaded vesicles (HNLV).
In this protocol, we also incorporated dye molecules (calcein) into the lipid vesicles.
Calcein molecules will serve as molecule/drug release model. We hope that when we heat
up the NPs inside the lipid vesicle via magnetic field heating, the heating will disturb the
lipid bilayer and calcein molecules will leak out of the vesicles (as illustrated in Figure
3.1). In this chapter, we explore the feasibility and the limitation of this proposed control
release mechanism.
4.1. Control Release via Magnetic Field Heating
In order to study the feasibility of control release application via magnetic field
heating, we followed the protocol in the previous chapter to prepare high density NP
loaded vesicles (HNLV). Calcein molecules were also incorporated into the vesicles.
Purification of HNLV from the excess lipid molecules, NP, and calcein molecules were
performed prior to the control release study. The purification were done via
centrifugation technique described in the previous chapter to ensure insignificant or
minimum amount of free calcein molecules in the solution prior to the control release
study.
First we need to show that calcein molecules were incorporated inside the HNLV.
We used the previously reported method 10 3 of using detergent Triton X-100 for
solubilization of the lipid bilayer, which lead to the vesicle deformation. This treatment
resulted in releasing any encapsulated materials. We applied this treatment to our purified
HNLV solution to deform the vesicles thus releasing NP and calcein molecules. We then
performed centrifugation to separate the NPs from the released calcein molecules in the
supernatant. Fluorescence spectroscopy was used to scan the supernatant for evidence of
the released calcein molecules. Figure 4.1 shows the fluorescence spectra of the
supernatants from the purified HNLV solutions with (solid line) and without (dash line)
Triton X-100 treatment. The spectra show clearly that calcein molecules were released
from the vesicle due to the Triton X-100 treatment.
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Figure 4.1. Fluorescence spectra of supernatants from the purified HNLV solution after
Triton X-100 treatment (solid line) and without the treatment (control) (dash line).
We also need to show that applied heat can disturb (melt) the lipid bilayer, thus
enable the release of calcein molecules out of the vesicles. These control experiments
were done by bulk heating (at certain temperature for 5 minutes) of the purified HNLV
solution which then immediately followed by then centrifugation to separate the NP from
the released calcein molecules in the supernatant. The released calcein were then
quantified with fluorescence spectroscopy. Figure 4.2 shows the fluorescence spectra of
the supernatants of the purified HNLV solutions after bulk heating treatments. It clearly
shows that it required the bulk heating treatment temperature higher than the lipid
transition temperature (Tm of DPPC = 42C) to deform or melt the lipid bilayer of
vesicles and thus enable the release of the encapsulated materials (calcein molecules).
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Figure 4.2. Fluorescence spectra of supernatants from the purified HNLV solution after
bulk heating treatment at temperature of 250C (dash line), 50 0C (dot line), and 550C
(solid line).
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Figure 4.3. Fluorescence spectra of the supernatants of the purified HNLV solutions after
(red line) or without (black line) the magnetic field treatment.
Finally, we investigated feasibility of control release application via magnetic
field heating. The idea is by applying AC magnetic field onto the purified HNLV solution
we hope to heat up encapsulated NP to deform or melt the lipid bilayer of the vesicle and
thus enable the release of calcein molecules (Figure 3.1). After applying the magnetic
field onto the purified HNLV solution, centrifugation was immediately performed to
separate the NP from the released calcein in the supernatant. Figure 4.3 shows the
fluorescence spectra of the supernatants with or without the magnetic field treatment. The
magnetic field was generated at frequency of 1 MHz with the amplitude of 3000 A/m.
The spectra clearly show almost no release of calcein molecules resulted from the
magnetic field treatment. Numerous other attempts at different frequencies and amplitude
of the magnetic field also indicated no release of calcein due to the magnetic field
treatment. This seems to indicate that magnetic field treatment unable to elevate the local
temperature of the HNLV to high enough temperature that allows the deformation of the
lipid bilayer and thus releasing the calcein molecules. These results seem to contradict
other published result.104 This contradiction is due to the fact that their experiments were
done with high concentration of magnetic NPs which cause the global temperature
increase of the solution rather than the actual local temperature of the NP.
4.2. The Limitation of Magnetic Field Heating
In order to understand why magnetic field heating unable to produce significant
temperature increase of the HNLV, we need to investigate the limitation of magnetic field
heating of magnetic NPs. Since it is currently impossible to probe directly the actual local
temperature of a single NP, most researchers study the magnetic field heating by
monitoring the bulk temperature increase of a high concentration solution of magnetic
NPs in an insulated sample container (Figure 2.2.(a)). Unfortunately this temperature
increase is due to the accumulation of energy dissipated by the high concentration of the
NPs to the surrounding medium inside an insulated sample container. Therefore, without
the insulation and/or at low concentration of NP, there will be no bulk temperature
increase of the solution. This is simply because the energy accumulated by a single NP
rapidly dissipated to its surrounding medium due to its high surface area to volume ratio.
In order to understand more about this limitation, other researcher has conducted
theoretical heat transfer approximation for the magnetic field heating of magnetic NPs. 46,
105, 106 In these theoretical calculations, a single NP is modeled as a spherical heat source
with constant power density (P) and radius (R) surrounded by medium with
homogeneous heat conductivity. To simplify the derivation, continuous temperature
profile were assumed at the interface between the NP and the surrounding medium. In
other word, it assumed negligible heat contact resistance at the interface. Assuming large
heating time, the equilibrium spatial temperature increase as a function of the distance (r)
from the centre of the spherical particle, described in the following equations:
R 2 P fr1 R 2 PAT(r) = R - - + r < R (4.3)6k" L R 3k"
A T(r) = r r > R (4.2)
Where kN and kM are the thermal conductivities for NP and medium respectively.
The power density (P) in this calculation is nothing but the experimental SAR
value in magnetic fluid hyperthermia study discussed earlier in chapter 2. Utilizing the
reported values of SAR, these theoretical calculations came to a conclusion that there is
only negligible temperature difference between the NP and the surrounding medium.
Heat was just instantaneously dissipated from the NP to the surrounding medium due
their high surface area to volume ratio. These researchers estimated that with the same
power density, the particle has to be as big as 6 mm in diameter to generate temperature
difference of 10 K. This clearly shown that utilizing magnetic NP as a heat source to
generate local temperature increase by mean of magnetic field heating is not feasible.
Our attempt to increaser the size of our system by encapsulation of magnetic NPs
into the liposomes though proven to be effective but it did not solve heating limitation
problem. Any attempt to increase the size of the NP-loaded liposomes is proven to be
unsuccessful. It is also not practical, considering the amount of NP materials needed to
increase the size of NP-loaded liposomes.
The other limitation of the magnetic field heating of magnetic NPs is its
selectivity of heating multiple different NPs. Although we have shown theoretically
(Figure 2.4) and experimentally (Figure 2.12 and Figure 2.13) that each magnetic NPs
reach its optimum heating rate at different frequency range, the heating is not completely
independent because at high frequency all the NPs are at their optimum heating rates.
This selectivity may be improved by adjusting the magnetic field amplitude at different
frequency range (Figure 2.5); but the feasibility of this approach is still unproven.
4.3. Alternative Heating Mechanism
Since nano size particles is the key component for our hypothesis, increasing their
size up to the millimeter range is not an option. Therefore the only option left to be
considered for generating a local temperature increase around the NPs is to increase the
NP power density as the heat source. This increase has to be in the range of a few orders
of magnitude to generate significant temperature increase. The next step is then to figure
out the mechanism to deliver such high power density to NPs so that they can convert it
to heat.
Recently, other researchers have managed to deliver very high power density of
energy pulsed onto the gold NRs. 10 7-110 This delivery mechanism was accomplished by
irradiating the gold NR sample with energy from femtosecond laser pulses at the
wavelength corresponding to the absorption wavelength of the gold NRs. Since the pulse
duration is only a few femtosecond, therefore the power density could be in order of
mega to gigawatts. With this high power density, femtosecond laser pulses can be utilized
to heat up or even melt the gold NRs. Figure 4.4 show the TEM images of gold NRs
before and after the exposure with femtosecond laser pulses. 1' It shows the NRs were
melted and shape transformed to more energetically favorable spherical form. This
heating mechanism of gold NRs can be an ideal solution for our hypothesis.
%
Figure 4.4. TEM images of gold nanorods (a) before and (b) after exposure to
femtosecond laser pulses. Reprinted with permission from the Annual Review of Physical
Chemistry. '
4.4. Summary
In this chapter we have shown that our proposed heating mechanism for magnetic
NP has failed to generate local temperature increase around the NP; therefore unable to
be utilized for our purpose of controlled release applications. We also discussed the
theoretical explanation of this physical limitation of magnetic field heating of magnetic
NP. From the understanding of this limitation, we then considered a new heating
mechanism by irradiation with femtosecond laser pulses. The laser exposure at the
wavelength corresponding to the gold NRs absorption wavelength can heat up and even
melt the NRs. We proposed to explore this mechanism for our hypothesis of utilizing
different types of NP for controlled release applications. For the remaining chapters in
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this thesis, we will discuss the application of this new proposed heating mechanism for
our proposed hypothesis. The discussion will started with the synthesis and selective
melting of different types of gold NRs. We then discussed the surface modification and
DNA conjugation of the gold NRs. Finally, we will also discuss the feasibility of this
mechanism for selective multiple controlled release applications.
Chapter 5
Synthesis of Gold Nanorods
Synthesis methods of noble metal NPs, such as colloidal gold NPs have been long
known for their use for staining glass. Scientific investigation of these methods did not
start until late 19th century by Michael Faraday. 112 In the recent years there are massive
works in perfecting the synthesis method to produce metal NPs at the precise sizes. S This
is mainly because the particles dimension governs their optical properties. The
morphology of these particles also governs their optical properties. The optical
absorption of gold nanospheres changes slightly with the increasing of their diameters.
An increase in NP diameter from 9 nm to 99 nm results in the red-shift of the absorption
peak by only 58 nm."13 On the other hand if we introduce anisotropy to the particle, such
as anisotropy growth of gold nanorods (NRs), their optical properties change significantly
with their dimensions and aspect ratios. Increasing the aspect ratio of gold nanorods can
result in red-shift of their longitudinal surface plasmon resonance peak in the order of
hundreds of nanometers. 113, 114 This key element of gold NRs' properties that make them
very suitable for our purpose; the need of multiple different NPs with different sizes,
morphologies, and optical absorptions.
Generally, there are three methods to synthesize gold NRs via wet chemistry. 115
The first one is template method, which is basically electrochemical deposition insides
nanoporous polycarbonate or aluminum template membrane. The second method is
electrochemical method which is basically a simple two-electrode electrochemical
system. The gold sacrificial anode is used as the source for the gold NR formation at the
platinum electrode with the help of hexadecyltrimethylammonium bromide (CTAB) and
small amount of tetradodecylammonium bromide as rod-inducing co-surfactants. The last
method, seeded growth method is the least difficult method with the highest yield. It uses
gold nanosphere as nucleation site for anisotropy growth with the help of CTAB
surfactants or binary co-surfactants. For the purpose of this study, we only explore the
last method. There are several classifications of this method. For our purposes, single
surfactant synthesis was performed to produce shorter capsule-like gold NRs
(nanocapsules). 116 The binary co-surfactants synthesis is performed to produce higher
aspect ratio gold NRs and followed by fast reduction step to create bone-shape
morphology (nanobones).l 7' 118 The remaining of this chapter discusses in details the
synthesis protocols for producing these two types of gold NRs.
5.1. Gold Nanocapsule Synthesis
Lower aspect ratio (AR) capsule-like gold NRs (nanocapsules) are synthesized
according to the single surfactant seed-mediated growth method by Murphy. 116 This
synthesis method is typically divided into two steps, the seed preparation and the growth
of NRs. The only surfactant used for these steps is hexadecyltrimethylammonium
bromide (CTAB). All the chemicals used for this synthesis were bought from Sigma-
Aldrich. Figure 5.1 illustrated both the seed preparation step and the growth step of the
gold NRs.
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Figure 5.1. Seed preparation and nanorod growth steps in gold nanorod synthesis.
Reprinted with permission from the American Chemical Society. 119
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Step 1. Gold seed preparation step. This step is basically rapid reduction of gold
ion to instigate nucleation for generating small gold nanospheres in the present of CTAB
surfactants. Typical protocol: 7.5 ml of 0.2 M CTAB solution was mixed with 0.25 ml
0.01 M HAuC14 in a beaker. While the solution was vigorously stirred, 0.6 ml of ice-cold
0.01 M of NaBH4 was added and the solution turned brownish yellow. Vigorous stirring
continued for another 2 min and then it was kept undisturbed at room temperature.
Step 2. Growth step of nanorods. Slow reduction of gold ion in the growth
solution slowly deposits gold atoms onto the added seeds in anisotropy way resulting in
elongation of the seeds to form gold nanocapsules. Typical protocol for growing
nanocapsules: 10 ml of 0.01 M of HAuCl 4 was added into 237.5 ml 0.1 M CTAB in a
glass bottle, and the solution turned orange. 1.5 ml of 0.01 M AgNO3 was added to the
solution, followed by gentle mixing. 1.6 ml of 0.1 M ascorbic acid was added into the
solution, followed by gentle inversion until the solution turned colorless. 2 ml of seed
solution was gently added to the growth solution. The solution sat on the bench
undisturbed overnight, during which it turned reddish brown.
The NR growth rate was found to level off within about 12 hours. Figure 5.2. (a)
shows that absorption profile of the nanocapsule solution. The longitudinal absorption
peak (Grey line) is around -800 nm; nicely overlap with the 800 nm laser profile (blue
line) with very minimum overlap with the 1100 nm laser profile (red line). JEOL 2000
was used to take TEM images of these particles. Figure 5.2 (b) shows the capsule-like
morphology of the nanocapsules. ImageJ was used for size analysis of these TEM
images. Figure 5.3 shows the statistical distributions from these analyses. The
nanocapsules' dimension is approximately -11 nm x 44 nm, with <AR> = 4.0.
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Figure 5.3. Size analysis of gold nanocapsules. Statistical distributions of (a) the
diameter, (b) the length, and (c) aspect ratio of the nanocapsules.
5.2. Gold Nanobone Synthesis
Higher aspect ratio gold NRs are synthesized according to the binary co-
surfactant seed-mediated growth method by El-Sayed. 118 These co-surfactants are
hexadecyltrimethylammonium bromide (CTAB) and
benzyldimethylhexadecylammonium chloride (BDAC). Similar to nanocapsule
synthesis, this synthesis method is also divided into two steps, the seed preparation step
and the NR growth step. After the growth rate levels off, we introduce additional step,
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fast reduction of the remaining gold ions in the growth solution, to generate bone-like
morphology onto the both ends of the NRs (nanobones). 117
Step 1. Gold seed preparation step. Typical protocol: 7.5 ml of 0.2 M CTAB
solution was mixed with 2.5 ml 0.001 M HAuC14 in a beaker. While the solution was
vigorously stirred, 0.6 ml of ice-cold 0.01 M of NaBH4 was added and the solution turned
brownish yellow. Vigorous stirring continued for another 2 min and then it was kept
undisturbed at room temperature.
Step 2. Growth step ofnanorods. Typical protocol: 125 ml of 0.001 M of HAuC14
was added into a mixture of 50 ml of 0.3 M CTAB and 75 ml of 0.3 M of BDAC
(benzyldimethylhexadecylammonium chloride) in a glass bottle, and the solution turned
orange. 5 ml of 0.004 M AgNO 3 was added to the solution, followed by gentle mixing.
1.5 ml of 0.1 M ascorbic acid was then added into the solution, followed by gentle
inversion until the solution turned colorless. 0.25 ml of seed solution was gently added to
the growth solution. The solution sat on the bench undisturbed overnight, during which it
turned reddish purple. The resulting product was high aspect ratio gold NRs.
Addition step. Growth step for dogbone feature. In order to turn these NRs to
nanobones, 4.63 ml of 0.1 M ascorbic acid was added into 250 ml of the NR solution,
followed by gentle mixing. Reactions were left undisturbed at room temperature. After
-3 hrs the solution turned blue, indicating formation of nanobones.
The nanobones should have aspect ratio higher than nanocapsules therefore their
absorption peak should be at higher wavelength than the nanocapsules'. Figure 5.4. (a)
shows that absorption profile of the nanobone solution. The longitudinal absorption peak
(Grey line) is around -1100nm, nicely overlap with the 1100nm laser profile (red line)
with very minimum overlap with the 800nm laser profile (blue line). It also has very
minimum absorption around -800nm; therefore it has very minimum overlap with the
nanocapsule absorption peak (Figure 5.2. (a) Grey line). These are very crucial for our
objective of selective excitation between these two types of gold nanorods. JEOL 2000
was used to take TEM images of these particles. Figure 5.4 (b) shows the bone-like
morphology of the nanobones. Image J was used for size analysis of these TEM images.
Figure 5.5 shows the statistical distributions from these analyses. The nanobones'
dimension is approximately were -17 x 89 nm with <AR> = 5.4.
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Figure 5.5. Size analysis of gold nanobones. Statistical distributions of (a) the diameter,
(b) the length, and (c) aspect ratio of the nanobones.
)
F.5"
0.4
M 0.3
0.2-
0.1-
Figure 5.
60
50
40
30
20
10
400 600 800 1000 1200
Wavelength (nm)
6. (a) Absorption profile and (b) TEM image of mixture solution.
2 4 6 8 10
Aspect Ratio
Figure 5.7. Aspect ratio distribution of the mixture solution
5.3. Summary
TEM images and size analyses of both nanocapsules and nanobones show their
differences in morphology, size and aspect ratio. Figure 5.6. (a) shows the absorption
profile of the mixture solution containing both nanocapsules and nanobones. There is
very minimal overlap of the SPRLong peaks and distinct separation between the two
SPRLong peaks, each corresponding to different type of gold NRs. This will enable us to
__ _IanC _ _ _ _ _ _ _ __ _ Cs~
excite the mixture of two types of NRs independently at two different wavelengths
corresponding to their SPRLong peaks. Figure 5.6. (b) shows TEM image of this mixture
solution. It clearly shows the distinction between nanocapsules and nanobones in term of
their sizes and morphologies. This will enable us to use TEM images for qualitative
characterization of the mixture after laser irradiations two different wavelengths
independently, corresponding to their SPRLong peaks. Figure 5.7 shows the aspect ratio
distribution of the mixture solution. The mixture solution has broader distribution due to
the combination of both nanocapsules and nanobones distributions. Therefore we can also
use the aspect ratio distribution analysis to quantitatively characterize the mixture after
laser irradiations two different wavelengths independently, corresponding to their
SPRLong peaks.
Chapter 6
Photothermal Heating of
Gold Nanorods
The phenomena which based on conversion of optical energy into heat are
commonly known as photothermal heating. Photoacoustic spectroscopy is considered the
earlier application of this idea of optical energy can be absorbed selectively by certain
materials and eventually converted into thermal energy; this photothermal heating effect
is detected by an indirect acoustic method. The more recent application of this
photothermal phenomenon is photothermal therapy; a medical application which use
certain dye that can absorb specific band of optical energy and then convert to thermal
heating for selective killing of the targeted cells.
The recent advancement of the photothermal therapy is the use of gold NPs. There
are a few advantages of using gold NPs as the absorbers. Due to its high absorption
coefficient, the use of gold NPs requires less laser power to reach the same threshold
temperature than the conventional dye absorbers.' 2 0 Gold NPs can easily be conjugated
with antibody for active targeting; increasing the selectivity of the photothermal effects to
just on the targeted cells. The wavelength of the light can also be customized by adjusting
the size or shape of the gold NPs to tune their maximum absorption peaks.
The ability to customize the wavelength of the incoming optical energy is very
beneficial because the biggest challenge in photothermal therapy is the selectivity of the
treatment. To ensure that the photothermal effect selectively destroying the targeted cells
without affecting the nearby cell, tissues, or hemoglobin, the absorption wavelength of
the absorbers have to be tuned to the wavelength where most biological entities will not
absorb. This wavelength band of light (650 nm - 900 nm) where hemoglobin and water
have minimum absorption is often referred as tissue optical window (Figure 6.1).121 This
leads to the most recent advancement of photothermal therapy, which is the use of gold
nanorods (NRs) as absorbers. Gold NRs are ideal absorbers because they can be
synthesized to have their absorption peaks within the tissue optical window. Their
absorption wavelength can be varied widely by adjusting their aspect ratio (Figure
6.2). "' Gold NRs also share the same other advantages as gold NPs have.
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Figure 6.1. Tissue optical window. This window is ideal for in-vivo application because
of the minimal light absorption of hemoglobin (>650 nm) and water (<900 nm).
Reprinted with permission from the Nature Publishing Group. 121
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Figure 6.2. Surface plasmon absorption spectra of gold nanorods of different aspect
ratios. Longer nanorods absorb light at higher wavelength. Reprinted with permission
from the American Chemical Society. 114
Photothermal heating of gold NRs can be accomplished by a variety of light
sources. Other researchers have shown that local temperature of the gold NRs can be
elevated by irradiation with continuous wave laser, nanosecond-pulsed laser, or
femtosecond-pulsed laser. 107, 122 With the same energy per pulse, the shorter the pulse the
higher the NRs local temperature increase. On the other hand, if the pulse duration is
shorter that heat dissipation time scale, the increased temperature can not be maintained.
Contrary to pulsed laser, the increased temperature can be maintained during the
continuous wave irradiation. For the purpose of our hypothesis, the following discussion
will focus more on the use of femtosecond-pulsed laser for photothermal heating of gold
NRs.
6.1. Femtosecond-pulsed Laser Heating of Gold
Nanorods.
Earlier studies on photothermal heating of gold NRs by femtosecond-pulsed laser
irradiation focused on how the irradiation induces shape transformation (melting).33 108,
110 These studies encompass investigations such as energy threshold to induce complete
melting, how the structural transition occurs, and what kind time scale of this transition.
Some of the recent works in this area in involve computational work to model the heat
dissipation around the gold NRs. 123 We will discuss these topics all together in this
section.
There are multiple processes occurring with the gold NRs during the
femtosecond-pulsed irradiation. First, the free electrons (electron gas) of the NRs absorb
the photons from the laser pulse during the pulse duration. The NR (lattice) temperature
increases due to the result of electron-phonon scattering; reaching a thermal equilibrium
between the electrons and lattice. As the particle temperature increases, heat dissipation
to the surrounding medium start to occurs through phonon-phonon interactions. The
actual time scale of these processes depends on the NR dimension, laser pulse duration,
and laser pulse intensity.123
Femtosecond pump-probe absorption spectroscopy study has been done to probe
the actual time scale of these processes. 10 8 A sample is hit by some pump pulse which
excites the NRs in the sample. After an adjustable time delay, a probe pulse hits the
sample, and its transmission is measured. By monitoring these transmission signals of the
probe pulses at various time delays, it is possible to obtain information about the NRs as
a function of time after excitation by the pump pulse. Selective excitation of the electron
gas of the NRs induce the transient bleaching of both the transverse and longitudinal
surface plasmon resonance bands and the existence of transient absorption band due to
broadening of both plasmon resonance bands. 124' 125 El-Sayed group utilized pump-probe
spectroscopy method to monitor this phenomenon to study the time scale of the electron-
phonon and phonon-phonon relaxation times. The observed these timescale to be around
- I - 4 ps 107, 113 and -100 ps33, 107 for electron-phonon and phonon-phonon relaxation
times respectively. El-Sayed group1 08 also used the pump-probe spectroscopy method to
monitor the permanent bleaching of NR absorption around 700-800nm (longitudinal
surface plasmon resonance (SPRong) peak of the NR) due to induced melting and shape
transformation of NR into spheres after high energy pump pulse excitation. They
observed that the time scale of the NR melting is at least 30-35ps. It is significantly
shorter than the time scale for the NR heat dissipation to surrounding medium; thus the
NR increased temperature is maintained long enough for the melting process to complete.
Figure 6.3 shows absorption spectra of gold nanorods solution exposed to 100 fs laser
pulses with energy of 40 pJ as a function of exposure time.'0 7 Figure 6.4 shows TEM
images of the gold nanorods before and after exposure of 100 fs laser pulses with energy
of 40 gJ for 7 min. 10 7 It resulted in shape transformation from nanorods to spheres
The El-Sayed group has performed simple absorption analysis and
thermodynamics calculation based on bulk values to estimate the threshold energy to melt
a single gold NR. They estimated that it takes an average of -60 fJ to melt a single NR
with dimension of 44 x 11 nm.1'0 9  Using the same approach, they also estimated the
lattice (NR) temperature as a function of laser fluence (Figure 6.5).33 Based on these
estimations and their experimental data, they concluded that the threshold for complete
melting of the gold NRs with 100fs laser pulses is about 0.01 J/cm2. 33
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Figure 6.3. Absorption spectra of gold nanorods solution exposed to 100 fs laser pulses
with energy of 40 pJ as a function of exposure time (arrow direction: increase of
exposure time). Reprinted with permission from the American Chemical Society. 07
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Figure 6.4. TEM images of the gold nanorods: (a) before and (b) after exposure of 100 fs
laser pulses with energy of 40 gJ for 7 min. Reprinted with permission from the
American Chemical Society. 107
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Figure 6.5. Lattice temperature as a function laser fluence for gold nanorods with
dimension of 44 x 11 nm. The two horizontal lines represent the bulk melting and boiling
temperatures. Reprinted with permission from the American Chemical Society.33
Recently, other researchers 123 have also performed computational work to better
estimate the surface temperature of NRs, surrounding water temperature, and the heat
transfer relaxation time scales. They used two-temperature model to estimate the electron
and lattice temperatures. Heat diffusion equation was used to describe the heat transfer
from the lattice to the surrounding medium. They also used thermal interface
conductance to estimate the coupling efficiency at the particle/water interface. The NR
with dimension of 48 x 14 nm 2 exposed to femtosecond laser pulses with fluence of 4.7
J/m2 and pulse duration of 250 fs. These parameters were chosen to avoid reaching
melting temperature of gold and critical temperature of water. Considering the length
scale of the problem, uniform temperature was assumed across the NR. They show
temperature distribution of the surrounding water around the NR at 70 ps after the
irradiation. Water temperature reaches to about 580K at the mid-length of the NR; while
the NR temperature is uniformly at 1079K. Thermal penetration depth is about 7 nm and
20 nm at 50 ps and 500 ps after the irradiation respectively. They also learned that
thermalization of the electrons is instantaneous compared to the electron-phonon and
phonon-phonon relaxation time scales. Thermal equilibrium between the electron and the
lattice was approximately 50 ps after the pulse. Negligible temperature difference at the
interface between NR surface and adjacent water was reached at approximately 500 ps
after the pulse.
6.2. Selective Melting of Two Types of Gold Nanorods
by Femtosecond-pulsed Laser Irradiations
The melting phenomenon of gold NRs upon the exposure of the femtosecond
laser pulses with high enough of laser fluence can be used as characterization tool for our
hypothesis. Since our goal is to use selective heating of multiple types of gold NRs for
selective multiple controlled release application, we can conceptually prove this concept
by showing that selective melting of multiple types of the gold NRs is achievable. To
perform this study, we need to synthesize two different types of gold NRs with different
sizes and morphologies to enable quantitative and qualitative analyses via TEM imaging
and absorption spectroscopy.
The Gold Nanorods: Nanocapsules and Nanobones
NR synthesis protocols were discussed in details in Chapter 5, they were designed
produce two different types of NRs with distinct ARs, morphologies, and SPRiong that
overlapped with each of the laser excitation wavelengths. Short NRs, "nanocapsules,"
were -11 nm x 44 nm, with <AR> = 4.0 (Figure 6.6 (d)) and SPRong at 800 nm (Figure
6.6 (b), black), coinciding with the short wavelength excitation at -800 nm (, 800). Long
NRs were bone-shaped (Figure 6.7 (d)), presumably due to preferential deposition at the
ends from the excess reducing agent. 117 "Nanobones" were -17 x 89 nm with <AR> =
5.4 and SPRIong at -1100 nm (Figure 6.7 (b), black), coinciding with the long
wavelength excitation at 1100 nm (Xiloo). Size analysis was done utilizing ImageJ. 5'
Mixtures allowed distinction between their populations by both the AR and morphology
(Figure 6.8 (d)). TEM sizing of a mixture exhibited broader AR distribution due to
overlapping peaks at 4.0 and 5.4 (Figure 6.8 (a), black). The 1.5 - 2.0 AR peaks were
from the small presence of synthesis byproducts (spheres, cubes, and stars). Spectral
overlap of nanocapsules and nanobones at both excitation wavelengths was minimal
(Figure 6.8 (b), black).
The Laser Experimental Setup
Laser irradiation was achieved using pulsed femtosecond lasers. For the 800 nm
irradiation, the 82 MHz output of a Ti:sapphire oscillator (Tsunami, Spectra-Physics) is
amplified at 1 kHz by a Ti:sapphire regenerative amplifier (Spitfire, Spectra-Physics)
pumped by the doubled output of a Q-switched Nd:YLF laser (Empower, Spectra-
Physics). The system produces 50 - 475 [tJ, with duration of 100 fs centered at -800 nm
at a 1 kHz repetition rate. Spot size was 6 mm. In a typical experiment, 50 CpL of sample
in 3x3 mm quartz cuvette was exposed to laser for 60 s.
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Figure 6.6. Melting nanocapsules. (a) AR histogram of nanocapsules exposed to
irradiation at 800 nm at 1.68 mJ/cm 2 (blue) and 1100 nm at 1.73 mJ/cm 2 (red), and
unexposed (black). (b) optical absorption spectra of nanocapsules upon exposure to 8soo
irradiation. Fluence (mJ/cm 2): 0 (black), 0.18 (red), 0.27 (green), 0.35 (blue), 0.70
(cyan), 1.06 (pink), 1.41 (orange), 1.68 (olive). (c) optical absorption of nanocapsules
upon exposure to i loo irradiation. Fluence (mJ/cm 2): 0 (black), 0.33 (red), 0.51 (green),
1.02 (blue), 1.39 (cyan), 1.73 (pink). TEM images of (d) unexposed nanocapsules
sample, (e) of Xsoo irradiated sample with a fluence of 1.68 mJ/cm 2, and (f) loo00
irradiated sample with a fluence of 1.73 mJ/cm2.
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Figure 6.7. Melting nanobones. (a) AR histogram of nanobones exposed to irradiation at
800 nm at 1.68 mJ/cm 2 (blue) and 1100 nm at 1.73 mJ/cm2 (red), and unexposed
(black). (b) optical absorption spectra of nanobones upon exposure to s00oo irradiation.
Fluence (mJ/cm 2): 0 (black), 0.18 (red), 0.27 (green), 0.35 (blue), 0.70 (cyan), 1.06
(pink), 1.41 (orange), 1.68 (olive). (c) optical absorption of nanobones upon exposure to
kXloo irradiation. Fluence (mJ/cm 2): 0 (black), 0.33 (red), 0.51 (green), 1.02 (blue), 1.39
(cyan), 1.73 (pink). TEM images of (d) unexposed nanobones sample, (e) of X800
irradiated sample with a fluence of 1.68 mJ/cm 2, and (f) lo100 irradiated sample with a
fluence of 1.73 mJ/cm 2.
2 4 6
Aspect Ratio
Fluence (mJ/cm 2)
---- 0
0.18
- 0.27
- 0.35
-0.70
- 1.06
-- 1.4 1
~1 111- 1~ I " " - 9 -BraE
The 1100 nm was generated via a homebuilt two-stage BBO/KNbO 3 optical
parametric amplifier pumped with the output of a Ti:Sapphire multipass amplifier
(Femtolasers: 30 fs, 1 kHz, 800 nm). Although the OPA is optimized for the production
of 3pm light, -2.6 - 13.6 pJ pulses of 1100 nm light were generated, the difference
frequency between 800 nm and 3 jgm, is generated by the OPA and used for the
experiments. The generated -1100nm has duration of 45 fs/pulse with repetition rate of 1
kHz. Spot size was 1 mm. In typical experiments, 50 jtL of sample in 3x3 mm quartz
cuvette were continuously mixed with pipette tip while being exposed to laser for 60 s.
After 800 nm or 1100 nm laser exposure, samples were diluted with their
corresponding solvents, 150 gL of 10 mM CTAB solution. UV-vis-NIR absorption scans
were performed to monitor the change of the absorption profile due the shape
transformation (melting). TEM imaging was also used to qualitatively confirm the
melting and perform quantitative size analyses.
Nanorod Melting and Its Selectivity
Laser irradiation of gold NRs at SPRlong caused melting,33' 34 accompanied by a
shape transformation to spheres. We studied the fluence dependence of nanocapsule and
nanobone melting by monitoring absorption. X800 irradiation of nanocapsules caused the
SPRong to decrease in intensity and blue-shift with increasing fluence, while the -520 nm
peak increased (Figure 6.6 (b)). This suggested that melting transformed nanocapsules
into shorter rods and spheres. TEM images of nanocapsules after X800 irradiation (Figure
6.6 (e)) and size analysis showed the AR distribution shift to lower values (Figure 6.6
(a), blue), supporting shape transformation to spheres. To show that melting of
nanocapsules requires matching irradiation wavelength to the SPRiong, we irradiated
nanocapsules at 1100 nm. The absorption spectrum was unchanged (Figure 6.6 (c)),
demonstrating no significant effect. TEMs of nanocapsules after XIo100 irradiation (Figure
6.6 (f)) were also unchanged, and size analysis showed little effect on the AR distribution
(Figure 6.6 (a), red).
The melting of the nanobones also required the matching of the irradiation
wavelength to their SPRIong. When nanobones were exposed to 11o00 irradiation, the 1100
nm peak decreased and blue-shifted with increasing fluence, while the -520 nm peak
increased (Figure 6.7 (c),). TEM imaging after ,1 0oo irradiation confirmed a shape
transformation into shorter "candy-wrap" or 4-shaped particles and spheres (Figure 6.7
(f)).126 Size analysis confirmed an AR shift to lower values (Figure 6.7 (a), red). so800
irradiation had essentially no effect, as evidenced by no significant change in absorption
scans (Figure 6.7 (b)). TEM after so800 irradiation (Figure 6.7 (e)) and size analysis
showed no significant changes in the AR distribution (Figure 6.7 (a), blue), indicating no
shape transformation occurred.
We also selectively melted either the nanocapsules or nanobones when both were
present in a mixture. The absorption scan had peaks at 800 and 1 100 nm due to the
presence of both species, and TEMs and AR histograms showed both populations
(Figure 6.8 (a), black and Figure 6.8 (d)). X80o irradiation caused the 800 nm peak to
decrease, leaving the 1100 nm peak relatively unaffected (Figure 6.8 (b)). After 8soo0
irradiation, fewer nanocapsules were present relative to nanobones. Spheres appeared,
resulting from the nanocapsule shape transformation (Figure 6.8 (e)). The AR peak at 4.0
decreased in intensity, and peaks at 3.0 or less increased, suggesting melting to form
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Figure 6.8. Selective melting of nanocapsule/nanobone mixtures. (a) AR histogram of
nanocapsules-nanobones mixture exposed to irradiation at 800 nm at 1.68 mJ/cm (blue)
and 1100 nm at 1.73 mJ/cm 2 (red), and unexposed (black). (b) optical absorption
spectrum of mixture after 80oo irradiation. Fluence (mJ/cm 2): 0 (black), 0.18 (red), 0.27
(green), 0.35 (blue), 0.70 (cyan), 1.06 (pink), 1.41 (orange), 1.68 (olive). (c) optical
absorption spectrum of mixture after 10oo irradiation. Fluence (mJ/cm 2): 0 (black), 0.33
(red), 0.51 (green), 1.02 (blue), 1.39 (cyan), 1.73 (pink). TEM images of (d) unexposed
mixture, (e) of 80soo irradiated mixture with a fluence of 1.68 mJ/cm 2, and (f) 100oo
irradiated mixture with a fluence of 1.73 mJ/cm 2.
spheres and shorter NRs (Figure 6.8 (a), blue). However, the peak at 5.4 was relatively
unchanged. These results support that 800oo irradiation melted only the nanocapsules but
not the nanobones. When the mixture was exposed to k10oo irradiation, the 1100 nm peak
decreased with increasing fluence (Figure 6.8 (c)) while the 800 nm peak increased,
presumably due to shape transformation of nanobones into 4-shaped NRs, which are
expected to absorb at wavelengths lower than 1100 nm.126 TEM imaging after 100oo
irradiation (Figure 6.8 (f)) showed that the nanobones disappeared, with primarily
nanocapsules, spheres, and 4-shaped NRs remaining. The AR peak at 5.4 decreased
while peaks at 4.0 or less increased, indicating nanobone shape transformation (Figure
6.8 (a), red). Evidently, k11 oo irradiation affected only the nanobones and not
nanocapsules. Thus, laser irradiation could selectively melt each species in a mixture,
corroborating single-type NRs melting studies.
6.3. Summary
Gold NRs can be heated up and even melted by exposure of femtosecond laser
pulses with high enough energy at the wavelength corresponding to the NRs' absorption
peak. We have shown that tuning the laser fluence, we can govern the degree of this
shape transformation. On top of it, we have also shown that we can selectively melted
two different types of NRs by matching the laser irradiation wavelength to their
absorption peaks. These two observations provide the crucial desired properties for our
hypothesis. They are the tunability and selectivity for the potential multiple controlled
release application.
Chapter 7
Surface Modification and
DNA Conjugation
In the last chapter we have shown the key properties of photothermal heating of
gold nanorods (NRs) that can potentially be desirable for our hypothesis in multiple
controlled release application. Before we can apply this heating phenomenon for the
controlled release application, we need a technique for loading the potentially-released
molecules onto the gold NRs as the carriers. We decided to use DNA oligonucleotides for
our drug model molecules and utilize the well known gold-thiol conjugation for loading
the DNA oligos onto the surface of gold NRs. Unfortunately, the resulting synthesized
gold NRs have their surface decorated by the bilayer cationic surfactants,
Cetyltrimethylammonium bromide (CTAB). Not only that this surfactant is known to be
toxic,127, 128 the overall positively charged of the NRs induces aggregation with the
negatively charged DNA oligos during the incubation. Thus the synthesized gold NRs are
proven to be problematic for bioconjugation. Therefore the first section of this chapter
will cover the NR surface customization technique that we develop to enable DNA
conjugation, which will be discussed on following section. The materials covered in
chapter were previously published in Langmuir 2 9 and ACS Nano 30
7.1. Ligand Exchange and Surface Customization
In the recent years, there are tremendous efforts in incorporating nanotechnology
(especially NPs) into biological applications and biomedical devices. Because of their
stability and size uniformity, inorganic NPs have been widely developed for these
purposes. Due to their tunable optical properties, metallic NPs especially gold NRs have
recently become very attractive for many biological applications such as gene delivery, 34
cell imaging,32 and photothermal therapy.131 However, their ligand functionalization has
been problematic for conjugation chemistries. Gold NR synthesis results with a double
layer of cationic surfactant, CTAB on their surface (NR-CTAB) for passivation. This has
been proven to be very problematic for bioconjugation due to non-specific adsorption of
DNA, cytotoxicity, 127' 128 aggregations, and their long-term stability. These factors have
severely limited the use of gold NRs for biological applications, especially when
compared to gold NPs (spherical form).' 32 In order to overcome these limitations such as
minimizing the non-specific adsorption during the bioconjugation to prevent aggregation,
ligand exchange technique is a must for surface customization. This technique must
produce NRs with uniform charge distribution to enable gel electrophoresis to assay
conjugation and DNA confirmation on the NR surface. There are previous reports of NR
ligand exchange techniques which separately permit conjugation to an antibody3 2' 133-135
or gel electrophoresis.3 6 However, there has not yet been a NR ligand exchange
technique that can enable ligand customization, biofunctionalization, and gel
electrophoresis. We have also tried these previously reported methods with very limited
success.32, 133-136 Due to the importance to this problem, we decided to develop our own
technique. We believe that by solving this problem, the resulting solution, customizable
ligand chemistry would broadly enhance the versatility of gold NRs in biological
applications.
The previously reported ligand exchange techniques involve a very simple
protocol of removing excess surfactants from the resulting synthesized nanorods and then
followed by simple incubation with the new ligands with or without sonication to avoid
aggregation.32.133-136 We develop a new technique with a very different approach with the
previously reported works. This new approach involves "round-trip" phase transfer of the
NRs for ligand customization and further DNA functionalization. Figure 7.1 shows the
schematic of our ligand exchange technique. The protocol is basically a two-step ligand
exchange. First, aqueous to organic phase transfer to strip the CTAB surfactant with
dodecanethiol (DDT) and followed by the organic to aqueous phase transfer to replace
DDT with negatively charged mercaptocarboxylic acid ligands. Resulting NRs are stable
in physiological buffers and exhibit narrow bands in gel electrophoresis. DNA
functionalization is straightforward, with minimal non-specific adsorption on the NR.
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Figure 7.1. Schematic of nanorod ligand exchange protocol and DNA conjugation. 129
We used the capsule-like gold NRs for this ligand exchange study. They were
synthesized by literature methods. 116 TEM imaging is used to determine the size of NR-
CTAB; their mean dimension is 43.5 + 11.9 nm (Figure 7.4 (a)). Centrifugation was
typically used to concentrate the synthesized NR-CTAB solution prior to the ligand
exchange protocol. The first step in the round-trip ligand exchange protocol utilizes
aqueous-to-organic phase transfer.137 138 lml of NR-CTAB solution at high concentration
(2-5E-8 M) in water was put into contact with 1ml of pure dodecanethiol (DDT) (Figure
7.1, Left Image). After addition of 4ml of acetone, the NRs were extracted into organic
DDT phase by swirling the solution for a few seconds, upon which the aqueous phase
became clear, indicating that no NRs remained (Figure 7.1, Middle Image).
The second step in ligand exchange protocol involves organic-to-aqueous phase
transfer to bring back the NRs back to aqueous phase with the desired ligands on their
surface. This phase transfer protocol follows the previously reported methods for gold
NPs and quantum dots. 139' 140 First we need to remove the excess DDT by centrifugation
technique. The DDT coated NR (NR-DDT) in the excess DTT phase was diluted with
toluene (iX) and an excess of methanol (5X), then spun down, and resuspended in 1 ml
toluene by brief sonication. The purified NR-DDT in toluene was then added all at once
to 9 ml solution of 0.01 M mercaptocarboxylic acid (MCA) in toluene at elevated
temperature while vigorously stirred. Three types of MCA ligands were used; they are
mercaptohexanoic acid (MHA), mercaptoundecanoic acid (MUDA), and
mercaptohexadecanoic acid (MHDA). The corresponding operating temperatures were
95oC for MHA and 70 0 C for MUDA and MHDA. 141- 143 The stirring and reflux continued
until visible aggregation of the NRs was observed; typically within 2 - 15 min. The
solution was then allowed to settle and cool to room temperature. The resulting
aggregation indicates that NRs were successfully coated by new MCA ligand; where the
resulting NRs (NR-MCA) are insoluble in toluene. The aggregates were then washed
once or twice with toluene via decantation, then once with isopropanol to deprotonate the
carboxylic acid. The aggregates spontaneously redispersed in IX TBE and were no
longer soluble in toluene (Figure 7.1, Right Image), suggesting residual DDT on the NR
surface is minimal.
Once the NR-MCA are resuspended in lx TBE buffer, they could have their
MCA coating optimized, be ligand exchanged with another species, or conjugated to
DNA (Figure 7.1). We incubated NR-MCA with 1 mM MCA in H20 or a H20/ethanol
mixture for further optimizing the MCA coating. We also performed further ligand
exchange of NR-MHA by incubating them in 1 mM aqueous solution of PEG-thiols with
various molecular weights (HS-PEG356, HS-PEG 1ooo, and HS-PEG5000). Pegylation of
gold NPs are known to increase the NP stability in the physiological environments during
the in-vitro and in-vivo experiments. Lastly we conjugated NR-MHA with fluorescently
labeled thiolated DNA 40mers (5' HS-TTTTT TTTTT TTTTT TTTTT TCGGC CCGTA
TAATT- TMR 3') using the charge screening method for DNA functionalization of Au
NPs.144
The width of the longitudinal surface plasmon resonance can be used to directly
probe the stability and aggregation of NRs. UV-vis spectra of ligand exchanged NRs with
MCA show shifts of the longitudinal plasmon with no significant broadening, indicative
of no aggregation (Figure 7.2 (a)). The peak shift is linear with chain length (Figure 7.2
(a), inset) as expected from the change in refractive index of the MCA coating with
increasing alkyl chain length.145-147 The longitudinal plasmon of NRs functionalized with
PEG-SH (Figure 7.2 (b)) also showed no significant broadening. We found that the
ligand exchanged NRs were stable even after 3 or 4 months of storage at high
concentration (-2E-8 M), and the plasmon peaks exhibited no significant changes in peak
width or position (Figure 7.3).
Heating gold NPs near the boiling point of the solvent in the present of surface-
active ligands such as alkanethiols over certain period of time may result in reduction in
average size of the particle due to digestive ripening.148 TEM imaging was used to probe
any change in size of the NR dimensions upon ligand exchange (Figure 7.4). TEM size
analysis determined mean dimensions of 43.2 x 11.8 nm for ligand-exchanged NRs, NR-
MHA (Figure 7.4 (b)). In comparison with the original synthesized NR-CTAB (Figure
7.4 (a)), there is no indication of any significant size change due to the ligand exchange
protocol. We also performed size analysis on other types of ligand-exchanged NRs (NR-
MUDA, NR-MHDA, NR-PEG 356, NR-PEGooo, and NR-PEGsooo) and observed
significant size change (Appendix B). We also observed no evidence of aggregation of
the ligand-exchanged NRs.
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Figure 7.2. UV-vis spectra of NRs upon ligand functionalization. (a) UV-vis spectra of
NR-CTAB (black), NR-MHA (red), NR-MUDA (blue), and NR-MHDA (green), inset,
longitudinal surface plasmon peak as a function of ligand length for SH-(CH 2)n-COOH;
(b) UV-Vis spectra of NR-MHA (black) before and after functionalization with PEG-SH,
NR-PEG356 (red), NR-PEGlooo (green), NR-PEGsooo (blue).129
FTIR spectroscopy was performed to confirm and probe the nature of the ligands
on the surface of gold NRs before and after the ligand exchange. FTIR spectroscopy
profile of purified NR-CTAB (Figure 7.5 (a), black) showed peaks at 958 cm -1 (arrow,
1) due to the quartemary amine stretch of CTAB (Figure 7.5 (a), green). The FTIR
spectroscopy profile of purified NR-MHA (Figure 7.5 (b), red) exhibited a COO- stretch
(1585 cm -', arrow, 2), shifted from the COOH stretch (1690 cm'- , arrow, 3) for MHA
alone (Figure 7.5 (b), blue), which is due to deprotonation of carboxylic acid of the
MHA monolayer on the NR surface. NR-MHA lack a S-H stretch (2613 cm - , arrow, 4)
but still have a C-S stretch (706 cm - , arrow, 5); indicating no free MHA molecules and
suggesting that the existing MHA molecules bound to the NR surface via sulfur-gold
bond.149-152 Similar observations can be inferred for other ligand-exchanged NRs
(Appendix B).
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Figure 7.3. UV-vis spectra of ligand exchanged NRs right after exchange (solid line) or
after 3-4 months storage at high concentration (dashed).129
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Figure 7.5. FTIR spectra of (a) cetyltrimethylammonium bromide, CTAB (green) and
NR-CTAB (black) before ligand exchange. (b) mercaptohexanoic acid, MHA (blue) and
NR-MHA (red) after ligand exchange. 129
We also performed gel electrophoresis to confirm the ligand exchange and probe
the mobility differences between the resulting ligand-exchanged NRs. Gel electrophoresis
was performed with 0.5% agarose gel in 0.5X TBE (Figure 7.6). NR-CTAB aggregate in
buffer, and do not move from the well (Lane 1). NR-MHDA (Lane 2), NR-MUDA
(Lane 3), and NR-MHA (Lane 4) all run in the positive direction, indicating that the
resulting ligand-exchanged NRs are negatively charged, thus confirm the ligand
exchange. The slight increasing trend in mobility is most likely due to a decrease in the
hydrodynamic radius (RH) of the NRs as a result of decreasing alkyl chain length;
considering the TEM images (Figure 7.4 and Appendix B) shows no significant
physical size change resulting from the ligand exchange protocols. NR-PEG356 (Lane
5), -PEGl000 (Lane 6), and -PEG5000 (Lane 7) all ran in the positive direction, which
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could be due to residual MHA on the NR surface. Mobility decreased with increasing
PEG chain length, most likely due to the increase in RH with longer PEG. Furthermore,
bands of all of the ligand functionalized NRs were narrow, exhibiting clear mobility
shifts with surface functionalization, enabling reliable quantitative Ferguson analysis to
find hydrodynamic radius' 36' 153 and -potential. 154
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Figure 7.6. Gel electrophoresis (0.5% agarose in 0.5X TBE) of before (Lane 1: NR-
CTAB) and after ligand exchange (Lane 2: NR-MHDA, Lane 3: NR-MUDA, Lane 4:
NR-MHA, Lane 5: NR-PEG 356, Lane 6: NR-PEG 1000, Lane 7: NR-PEGsooo). 129
7.2. Gold Nanorod - DNA conjugation
Any attempt to conjugate DNA oligonucleotides onto the surface of synthesized
NR-CTAB will result in instantaneous aggregation due to the formation of network
between the positively charged NR-CTAB with negatively charged string of DNA oligos.
Own the other hand; the negatively charged ligand exchanged NRs can be easily
conjugated with DNA oligos via charge screening method. 44 For example, after ligand
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exchange the resulting NR-MHA was incubated with fluorescently labeled thiolated
DNA 40mers (5' HS-TTTTT TTTTT TTTTT TTTTT TCGGC CCGTA TAATT- TMR
3') (SH-DNA); we called this solution as "incubation reaction". We also incubate NR-
MHA with fluorescently labeled non-thiolated DNA; we call this solution as "incubation
control". Figure 7.7 shows the UV-Vis spectra of before and after DNA conjugation.
DNA conjugation (Figure 7.7, red solid line) did not broaden or shift the longitudinal
SPR significantly relative to the NR-MHA peak (black dash line); indicating no
aggregation after DNA conjugation. Furthermore these UV-Vis spectra of the NR-DNA
conjugate was taken 7 days after the conjugation was performed, indicating its long-term
stability. Gel electrophoresis was performed to confirm the NR-DNA conjugation via Au-
S bonding. NR-DNA conjugates of the incubation reaction (Figure 7.8, Lane 3) ran
slower relative to NR-MHA (Lane 1), indicating a RH increase. Bands are narrow enough
to permit Ferguson analysis of the NR-DNA. The narrow band also indicates no
aggregation and a uniform charge distribution. The NRs of the incubation control
solution exhibited no significant mobility shift, indicating minimal non-specific
adsorption (Lane 2). The fluorescent of free DNA band of the incubation reaction
solution (Lane 3) decreases in intensity compared to a control sample of equal
concentration of the thiolated DNA by itself (Lane 5) while the non-thiolated DNA does
not (Lane 2 vs Lane 4), also supporting covalent attachment. Fluorescence spectroscopy
also indicated NR-DNA conjugation. Supernatant fluorescence decreased (Figure 7.9 (a),
red solid line) from its original value (red dash line), indicating that DNA was removed
from solution by conjugation to the NR. Nonthiolated DNA showed a smaller decrease
(Figure 7.9 (a), black line, solid vs. dash line), indicating that covalent conjugation was
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favored over non-specific adsorption. NR concentration was estimated using the
extinction coefficients of the longitudinal plasmon band peak, ; = 4.6x10 9 M-1 cm-'. 5
Fluorescence spectra quantified -41 DNA/NR.
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Figure 7.7. DNA conjugation. UV-vis spectra of NR-MHA (mercaptohexanoic acid;
black dash line), NR-MHA + non-thiolated DNA (black solid), NR-MHA + thiolated
DNA (red line). 129
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Figure 7.8. Gel electrophoresis (0.5% agarose in 0.5X TBE) of DNA functionalization of
NR-MHA (UV image), Lane 1: NR-MHA, Lane 2: NR-MHA incubated with non-
thiolated DNA, Lane 3: NR-MHA incubated with thiolated DNA, Lane 4: non-thiolated
DNA, Lane 5: thiolated DNA. All DNA was functionalized with a 3' TMR. 129
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Gel electrophoresis can also be used to purify the DNA conjugated NRs (NR-
DNA). NR-DNA bands had lower mobility than free DNA band therefore they were not
at the same position as the free DNA bands in the agarose gels (Figure 7.8, lane 2 and 3).
Thus the NR-DNA bands were free from the unconjugated DNA; these bands can be cut
to extract the purified NR-DNA sample. The extraction method typically involved of
dissolving the gel bands in lxTBE buffer overnight and followed by centrifugation with
0.2gtm filtered tube to separate the NR-DNA from the gel. Incubation of purified NR-
DNA with mercaptohexanol (MCH) can displace the conjugated DNA; which then can be
quantified by fluorescence spectroscopy. 156 Typically, purified NR-DNA sample were
incubated in 1 mM MCH overnight, displacing the DNA from the NRs. Displaced DNA
was then separated from the NRs by centrifugation and quantified by fluorescence
spectroscopy (Figure 7.9 (b), red solid line). As a control, a fluorescence scan was taken
of the supernatant of the same NR-DNA solution without MCH treatment (red dash
line). The scan was taken 9 days after the conjugation, indicating there was no significant
detachment of DNA from NR-DNA conjugates over this period of time. The gel-purified
NRs incubated with nonthiolated DNA was also treated with MCH and its supernatant
exhibited no significant fluorescent peak (black solid line), indicating minimal non-
specific adsorption. Quantification by fluorescence spectroscopy determined the
conjugation ratio of approximately 28 HS-DNA/NR. This DNA loading translates to
approximately 2 pmol DNA/cm 2, which is the same order of magnitude for DNA
conjugation with gold nanowires 157 or nanoparticles. 58
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Figure 7.9. DNA conjugation. Fluorescence spectroscopy of (a) supernatants of NRs
conjugated with: thiolated DNA (red solid line) or non-thiolated DNA (black solid line).
Fluorescence spectroscopy of controls (DNA without NRs): thiolated DNA (red dash
line) or non-thiolated DNA (black dash line). (b) Supematants of MCH treated NRs
conjugated with: thiolated DNA (red solid line) and non-thiolated DNA (black line).
Spectrum of supernatant of NR conjugated with thiolated DNA without MCH treatment
(red dash line). 129
7.3. Summary
In this chapter we have shown that we can successfully performed ligand
exchange of gold NRs via round-trip phase transfer method. The ligand exchange
protocol can varied to enable ligand customization and straightforward DNA conjugation.
Ligand-exchanged NRs were proven to have uniform charge distribution; enabling their
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long-term stability in physiological buffers and quantitative analysis by gel
electrophoresis. The straightforward DNA conjugation with the ligand-exchanged NRs
will enable us to conjugate multiple DNA each onto different type of gold NRs for our
hypothesis. This method for modifying the surface chemistry of gold NRs will also
enhance their versatility in biological applications such as therapy, sensing, and imaging.
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Chapter 8
Selective Release of
Multiple DNA
Oligonucleotides from Gold
Nanorods
In the previous chapter we have shown that we can customize the ligands on the
surface of gold nanorods (NRs) to enable straightforward DNA conjugation. In this
chapter we will discuss the development of a system of two types of NR-DNA conjugates
for the purpose of our hypothesis; selective release of multiple DNA oligonucleotides
from different types of gold NRs. Figure X. 1 show the schematic of the hypothesis. We
then discuss how we prove the selective release hypothesis by selective melting of
different NR via utilization of two different femtosecond laser with pulses center at two
different wavelengths, each corresponding to different gold NRs' absorption peak. The
materials covered in chapter were previously published in ACS Nano. 130
8.1. A System of Two Types of NR-DNA Conjugates
In the introduction chapter we have discussed the need for drug carrier strategy
that can enable selective multiple drug delivery. An ideal method would involve the
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ability to externally control the release of each drug independently. As mentioned earlier,
we proposed the utilization of selective heating different types of NPs to release multiple
types of DNA oligonucleotides, each conjugated to different NPs. In the DNA - gold NR
system, we propose the utilization of two different types of gold NRs (Chapter 5) which
were tuned two have two different absorption peaks (longitudinal surface plasmon
resonance) with minimal overlap when they are mixed. This property will enable
selective excitation by laser irradiation (Chapter 6). The two different types of gold NRs
were also tuned to have distinct difference in their sizes, aspect ratios, and morphologies.
These will enable qualitative and quantitative analyses after laser irradiation (Chapter 6).
In Chapter 6 we have also shown that pulsed laser excitation in resonance with the NRs'
longitudinal surface plasmon resonance (SPRlong) can heat NRs locally to high
temperatures, inducing melting. Since SPRlong is tunable by changing NR aspect ratio
(AR), we have also shown that the two types of NRs (nanocapsules and nanobones) with
different ARs can be excited and melted independently at different wavelengths
corresponding to their SPRong. This triggered melting is exploitable for controlling the
release of biomolecules conjugated to the NRs.34 If different NRs are conjugated to
different molecules, this strategy could be utilized for orthogonal triggered release of
multiple species. Here we demonstrate selective release of two distinct DNA strands from
two different NRs by matching laser excitation wavelength to the NRs' SPRong (Figure
8.1).
DNA Conjugation
A system consisted with two types of DNA conjugated gold NRs was used to test
our hypothesis, as illustrated in Figure 8.1. Two different NRs, nanocapsules and
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nanobones (Chapter 5), were ligand exchanged with mercaptohexanoic acid (MHA). The
two different ligand-exchanged NRs were then conjugated to two different thiolated
40mers DNA, each labeled with different fluorophore and thus distinguishable. These
40mers DNA oligonucleotides had the same sequence of 5' HS-TTTTT TTTTT TTTTT
TTTTT TTTTT TCGGC CCGTA TAATT 3'; each fluorescently labeled at the 3' ends
with either FAM (FAM-DNA-SH) or TMR (TMR-DNA-SH) (both were purchased from
Sigma Aldrich) were conjugated to nanocapsules and nanobones respectively via gold-
thiol covalent bond (Figure 8.2). The DNA-NR conjugation was achieved following
charge screening protocols. 129, 144, 158 Charge screening (salt-aging) was necessary to
compensate for electrostatic repulsion between the NRs and DNA. Sodium dodecyl
sulfate (SDS) surfactant was used to increase the stability of NRs during the salt-aging
process. First, FAM-DNA-SH and TMR-DNA-SH were reduced by tris[2-carboxyethyl]
phosphine (TCEP) with TCEP:DNA ratio of 100:1. Then nanocapsules or nanobones in
the concentration range of 5-10 nM were incubated with the reduced FAM-DNA-SH or
TMR-DNA-SH, respectively, in 10 mM phosphate buffer with 0.3% SDS concentration.
DNA to NR ratios were 200 FAM-DNA-SH/nanocapsule and 400 TMR-DNA-
SH/nanobone. After 3 hrs of incubation, charge screening was performed with salting
buffer of 0.6 M of NaC1, 0.3 % SDS in 10 mM phosphate buffer. 8 L of the salting
buffer were added to the 200 pl of the conjugation solution every 30 min followed by I Os
sonication. This step was repeated for total 5 times, which was then followed by
overnight incubation.
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Gel Electrophoresis
Two methods were used to confirm NR-DNA conjugation. First, gel
electrophoresis was used to observe mobility changes to assay any change in the
hydrodynamic radius of DNA-conjugated NRs. Gel electrophoresis was performed with
0.5 % agarose gels in 0.5x TBE (Figure 8.3). Glycerol was used for loading the samples
to ensure the NRs stayed in the wells prior to traveling in the gel matrix. Nanocapsules
ran toward the positive electrode, indicating a negative charge from the
mercaptohexanoic acid ligand coating the surface (Lane 1). Nanocapsules incubated with
thiolated FAM-labeled DNA 40mers (FAM-DNA-SH) were retarded, indicating a larger
hydrodynamic radius due to conjugation (Lane 2). The UV image of the gel (Figure 8.3
(b)) showed that the free FAM-DNA-SH band after conjugation (Lane 2) was dimmer
than the equal-concentration free FAM-DNA-SH alone (Lane 3), also supporting
conjugation to nanocapsules, which quench fluorescence. Nanobones showed similar
results for thiolated TMR-labeled DNA 40mers (TMR-DNA-SH). The TMR-DNA-
nanobones band (Lane 5) was retarded compared to nanobones alone (Lane 4), and the
free TMR-DNA-SH band (Lane 5) was dimmer than the equal-concentration free TMR-
DNA-SH alone (Lane 6). These results confirm DNA conjugation to both species.
Fluorescence Spectroscopy
The second method to confirm the conjugation was quantification of the DNA
loading onto the NR surface. This was accomplished by two methods. First, we
quantified the free unconjugated DNA via fluorescence spectroscopy of the fluorophore
labels (FAM for nanocapsules and TMR for nanobones) with or without NRs present.
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This was done by collecting the supematants after centrifugation of the conjugation
solution.159 The second method was accomplished by chemical displacement of the
conjugated DNA using literature methods. 12 9, 156 Briefly, purified NR-DNA conjugates
were incubated in 1 mM MCH overnight; displacing the DNA from the NRs. Free
displaced DNA was separated from the NRs by centrifugation and quantified by
fluorescence spectroscopy. Both methods gave similar estimates of the DNA loadings of
approximately 114 DNA/nanocapsule and 284 DNA/nanobone.s 55
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Figure 8.1. Schematic overview of the selective release. Laser irradiation of DNA-
conjugated nanocapsules (blue ovals) and nanobones (red bones) are exposed to X800
irradiation (left), which melts the nanocapsules and selectively releases the conjugated
DNA (labeled by FAM (green triangles)). Exposure to kloo irradiation (right) melts the
nanobones, selectively releasing the conjugated DNA (labeled by TMR (orange stars)).
112
i~ii
~i "N
-S-TTTTT TTTTT TTTTT TTTTT TTTTT TCGGC CCGTA TAATT-
-S-TTTTT TTTTT TTTTT TTTTT TTTTT TCGGC CCGTA TAATT
Figure 8.2. DNA-nanorod thiol conjugation. 40mers DNA oligonucleotides with the
same sequence of 5' HS-TTTTT TTTTT TTTTT TTTTT TTTTT TCGGC CCGTA
TAATT 3', fluorescently labeled at the 3' ends with either FAM (FAM-DNA-SH) or
TMR (TMR-DNA-SH) were conjugated to nanocapsules and nanobones respectively via
gold-thiol covalent bond.
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Figure 8.3. Gel assay of DNA-nanorod conjugation. (a) white light and (b) UV images
of gel electrophoresis. Lane 1: nanocapsules, 2: FAM-DNA-SH + nanocapsules, 3:
FAM-DNA-SH, 4: nanobones, 5: TMR-DNA-SH + nanobones, 6: TMR-DNA-SH.
Dashed lines indicate positions of wells. Positive direction indicated.
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8.2. Selective Controlled Releases
Finally, the mixture of purified FAM-DNA-nanocapsules and TMR-DNA-
nanobones was laser irradiated for selective release (Scheme on Figure 8.1). We used the
same laser experimental setup as for the selective melting study in Chapter 6. After 800
nm or 1100 nm laser exposure, samples were diluted with their corresponding solvent,
150 pL of lx TBE. Samples were then centrifuged at 16,100 g for 5 min to remove the
NRs and collect the supernatants. Fluorescence spectroscopy was used to quantify the
released DNA in supernatants. We quantify the fluorescence intensity of FAM due to
FAM-DNA released from nanocapsule and TMR due to TMR-DNA released from
nanobones.
After so800 irradiation, the supernatant fluorescence at 520 nm increased with
fluence (Figure 8.4 (a), solid lines), illustrating FAM-DNA release. However, increased
fluorescence at 580 nm was much lower, indicating insignificant TMR-DNA release
(dashed lines). Therefore, so800 irradiation could selectively release FAM-DNA from
nanocapsules, while leaving TMR-DNA-nanobones undisturbed. At fluences <1.00
mJ/cm 2, FAM-DNA release was selective, reaching -70 % while TMR-DNA release was
< 10 %, where 100% was the amount released by MCH treatment (Figure 8.4 (b)). For
fluences > 1.00 mJ/cm 2, release of TMR-DNA from nanobones did increase, while FAM-
DNA release was saturated.
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Figure 8.4. Selective release - X800oo irradiation. (a) Fluorescence spectra of supernatant
after Xsoo irradiation, FAM-DNA peaks (solid lines) and TMR-DNA peaks (dashed
lines). Fluence (mJ/cm 2):0 (black), 0.18 (red), 0.27 (green), 0.35 (blue), 0.70 (cyan),
1.06 (pink), 1.41 (orange), 1.68 (olive). (b) % released of FAM-DNA (green triangles)
and TMR-DNA (orange stars) as a function of 80oo laser fluence.
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Figure 8.5. Selective release - Xlloo irradiation. (a) fluorescence spectra of supernatant
after X1100 irradiation. FAM-DNA peaks (solid lines) and TMR-DNA peaks (dashed
lines). Fluence (mJ/cm 2): 0 (black), 0.33 (red), 0.51 (green), 1.02 (blue), 1.39 (cyan),
1.73 (pink). (b) % released of FAM-DNA (green triangles) and TMR-DNA (orange
stars) as a function of 1100oo laser fluence.
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500
When the mixture was exposed to X1loo irradiation, supernatant fluorescence at
580 nm increased (Figure 8.5 (a), dashed lines), while intensity at 520 nm was
negligible (solid lines), illustrating TMR-DNA release with no significant FAM-DNA
release. TMR-DNA release was selective, reaching 50 - 60% while FAM-DNA release
was < 10% (Figure 8.5 (b)). Therefore, X 0loo irradiation could selectively release TMR-
DNA from nanobones, while leaving FAM-DNA-nanocapsules undisturbed. Evidently,
the NRs undergo a shape transformation at these fluences (Figure 6.10 - 6.12), which
probably induces release due to gold-thiol bond dissociation. 160 ' 161 We observed that re-
adsorption of the released DNA back onto the melted gold NRs after a long period of
time (3 months) was minimal (Figure C.1, Appendix C). We also observed that the laser
irradiation had no effect on the fluorescence of the FAM-DNA and TMR-DNA (Figure
C.2, Appendix C).
We confirmed that released DNA was still functional and could hybridize to a
complement. Released DNA was incubated with DABCYL-functionalized DNA
complements (5' DABCYL-AATTATACGGGCCG 3'), and hybrid formation confirmed
by melting curves. Dequenching of FAM at 520 nm (Figure 8.6 (a), green) and TMR at
585 nm (Figure 8.6 (b), orange) was monitored with increasing temperature. Both
curves were characteristic of functional hybrids, with Tm's coinciding with that of the
original (control) DNA (Tm = 42 "C) (Figure 8.6 (a), black and Figure 8.6 (b), black).
Original (control) DNA is the original source DNA without going through NR
conjugation and laser irradiation.
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Figure 8.6. Melting Curve of (a) original (control) (black) and released (after 800oo
irradiation of 1.68 mJ/cm 2 ) (green) DNA-FAM and (b) original (control) (black) and
released (after X1100 irradiation of 1.73 mJ/cm 2) (orange) DNA-TMR.
8.3. Summary
First, we have shown that we can effectively load different DNA oligonucleotide
onto different type of gold NRs. The DNA-NR conjugation can be confirmed and
quantified with gel electrophoresis and fluorescence spectroscopy. We then successfully
prove our hypothesis by demonstrating the selective release of two distinct DNA
oligonucleotides from two different NRs via selective laser-induced melting of NRs.
This selectivity was accomplished by selective irradiation of two different NRs with
femtosecond laser pulses at two different wavelengths corresponding to their longitudinal
absorption peak (SPRlong). Because laser fluence governs the degree of NR melting, yield,
and specificity of DNA release, these controlled releases are externally tunable. Releases
were efficient (50-80%) and the released oligonucleotides were still functional. This
proof of concept is potentially a powerful method for multiple-drug delivery strategies.
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Chapter 9
Conclusions
9.1. Summary
As mentioned in the introduction chapter of this thesis, its main objective is an
exploration in formulating a new concept of controlled release of biomolecules by
utilizing the NPs. Due to the heat sensitive nature of the biomolecule conjugation with
NPs and the fact that both of them are in the same length scale, the main idea behind this
exploration is utilizing the heating of the NPs to govern the release of the conjugated
biomolecules. There are four specific aims of our exploration. They are to explore
methods for delivering energy to the NP from external energy sources in order to heat up
the NP, to show that we can selectively heat different types of NPs, to develop bio-nano
system, and to use this system for feasibility study of our idea of selective controlled
release of multiple different types of biomolecules via selective heating of different types
of NPs. For the first specific aim, we investigated two NP-heating mechanisms; the
magnetic field heating of magnetic NPs and the photothermal heating of gold NRs. We
investigated feasibility of each of these two mechanisms in fulfilling the three remaining
specific aims.
We discuss extensively the theoretical prediction and experimental results of our
magnetic field heating study in Chapter 2. Independent heating of multiple types of NPs
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is theoretically possible by exploiting the size and material dependence of the power loss
equation. Preliminary results from the bulk magnetic field heating (SAR) experiments of
two different types of magnetic NPs (Fe 30 4 and Au/Fe NPs) show that independent
heating has feasible potentials. Each type of NPs reaches the optimum heating rate at
different frequency range of the applied magnetic field. Therefore it is exploitable for
selective heating between the two types of magnetic NPs by choosing the appropriate
frequencies.
We have also developed a protocol for synthesizing lipid vesicles that can be
loaded with high number of Fe 30 4 NPs and dye molecules as drug model (Chapter 3). We
accomplished this by systematically study the phase behavior of the lipid-NP system. At
certain concentrations of lipid and NPs, it is possible to obtain the lipid vesicle
morphology and the maximum loading of the NPs into these vesicles. We showed that by
elevating the solution temperature (bulk heating) we can disturb the vesicle morphology
(induce lipid phase transition) and thus release the encapsulated dye molecules.
Unfortunately, exposure to the magnetic field does not produce the same effect. This is
due to the physical limitation of the magnetic field heating experiment; low-power energy
delivered to the NP to produce no significant local temperature rise with respect to the
ambient surrounding medium (Chapter 4). Therefore magnetic field heating is not
feasible for our proposed controlled release application.
The physical limitation of the magnetic field heating of magnetic NPs led us to
the next exploration of the second heating mechanism. In agreement with other
researchers, we showed that we can heat up and even melt gold NRs via photothermal
heating by exposure to the femtosecond laser pulses. Since one of the specific aims in our
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objective is to show that we can selectively heat up different type of NPs, we first show
our gold NRs synthetic capability in Chapter 5. We were able to synthesize two different
types of gold NRs; they are distinct in size, aspect ratio, and morphology. Their
absorption profiles had very minimal overlap; therefore we were able to selectively excite
them by femtosecond laser pulses at two different wavelengths corresponding to their
longitudinal surface plasmon resonance peaks (SPRlong). This selective excitation enabled
us to selectively heat up (even melt) the two different types of gold NRs (Chapter 6).
We then showed that we can effectively load different DNA oligonucleotide onto
different type of gold NRs (Chapter 7). Ligand exchange of the NRs was required prior to
conjugation to avoid aggregation. We developed the ligand exchange protocol to enable
customization of the overall charge of the NRs and the thickness of the surface ligand
monolayer. The DNA-NR conjugation can be confirmed and quantified with gel
electrophoresis and fluorescence spectroscopy. We then successfully proved our
hypothesis (the final specific aim) by demonstrating the selective release of two distinct
DNA oligonucleotides from two different NRs via selective laser-induced melting of NRs
(Chapter 8). This selectivity was accomplished by selective irradiation of two different
NRs with femtosecond laser pulses at two different wavelengths corresponding to their
SPRong. Because laser fluence governs the degree of NR melting, yield, and specificity of
DNA release, these controlled releases are externally tunable. The release yield was very
high; up to -80% of the load can be released. DNA melting study also showed that the
released DNA oligonucleotides were still functional.
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9.2. Conclusions
Finally, we have shown that our idea of utilizing the selective heating of different
types of NPs for selective multiple controlled released applications is very feasible. We
formulated our proof of concept through accomplishment of a sequence of four specific
aims. We accomplished all by utilizing the photothermal heating of gold NRs via
irradiation with femtosecond laser pulses. Pulsed laser excitation in resonance with their
absorption peak can heat and melt the NRs; this is exploitable for controlling the release
of biomolecules conjugated to the NRs. NRs with different aspect ratios absorb light at
different wavelengths thus can be excited independently. We have successfully
demonstrated selective release of two distinct DNA oligonucleotides; each released from
different type of NR. This was accomplished by the laser excitation at two different
wavelengths corresponding to the NRs' absorption peaks. The releases were very
selective, efficient, and externally tunable by adjusting the laser fluence. The released
payloads (DNA oligos) were still functional.
Limitations
Even though the proof of concept of our hypothesis is very promising, we believe
that our concept is not immune to certain limitations. The first limitation is the
consistency of the NR synthesis. Although NR synthesis recipe has been widely
published, the repeatability of these recipes is very sensitive to the quality of the
chemicals used for the synthesis."19 Thermal degradation may also be an issue if payloads
are loaded to close to the NR surface. 1 62 This can be overcome by utilizing spacer
molecules between the NR surface and the active loads; thus further study on utilizing the
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appropriate spacer is a must. In the much bigger picture, the toxicity of NPs in general
has to be extensively investigated before any inorganic NPs can be practical for in-vivo
biological applications. The femtosecond laser setup itself is also known to be expensive.
Advantages
Although our concept can not escape from certain limitations, we still believe
that our proof of concept is still fundamentally sound and we hope to inspire other
researchers to investigate more or utilize it for different applications. We are hopeful in
many ways due to the fact that our concept exploits the very fundamental material
property of gold NRs; the independent of absorption profile of NRs with different ARs.
With appropriate tuning of the NR synthesis, this concept is expandable to beyond two
species. Since conjugation requires only standard thiol conjugation, it is potentially
applicable to a wide range of molecules. NRs have relatively large surface area and the
capacity to loads hundreds of molecules, and -80% of the payload can be released. NR
surface are also chemically versatile, with customizable coatings, and others have
demonstrated active targeting by decorating the NRs with moieties such as antibodies and
cell receptor ligands. These advantageous factors clearly indicate that our proof of
concept of selective triggered release from gold NRs is potentially a powerful technique
for improving controlled release applications such as multiple drug delivery strategies;
the very problem that motivated our thesis work.
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9.3. Further Studies
Effect of the spacer length
In our study of controlled release of DNA oligonucleotides gold NRs due to
heating/melting of the NRs, we used 40mers DNA oligonucleotides (5' HS-TTTTT
TTTTT TTTTT TTTTT TTTTT TCGGC CCGTA TAATT 3', fluorescently labeled by
FAM or TMR at the 3' ends) with the first 26 poly-T sequence acts as a spacer. This
spacer is used to ensure that the remaining (essential) part of oligonucleotides (the later
14 sequence) undamaged by the potential thermal degradation due to the heating of the
NRs. 162 To check its functionality, we hybridized this essential part with its complement.
The complement was functionalized with a 5' DABCYL (5' DABCYL-
AATTATACGGGCCG 3') to quench the FAM and TMR in the hybridized state. Melting
curves were obtained in a temperature controlled Peltier module of the fluorescence
spectrometer, where the increase of fluorescence of either FAM or TMR was monitored
as a function of increasing temperature (Figure 8.4 (b) inset and Figure 8.5 (b) inset).
Further study to investigate on whether this spacer can be damaged by the
photothermal heating is certainly necessary to better understand the fundamental heating
profile around the NRs. One possible experimental investigation would be varying the
length of the spacer and then investigate whether the remaining (essential) part of the
DNA is still functional. This study will also tell us on how far away from the NR surface
the essential payload needed to be loaded to guarantee that when they are released they
will be functional.
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Surface customization for cell uptake
In order for our proposed controlled release method to be feasible for in-vivo
experiments, we must first study the cellular uptake of the NRs. Other researchers have
conducted some preliminary works in maximizing the NRs cellular uptake while
maintaining the cell viability. 163- 165 We hope that our NR ligand exchange method which
enables NR surface customization' 29 will inspire others to utilize our method to further
optimize the efficiency of the uptake. In the hope that we will get a better understanding
on the fundamental concepts such as which surface customization will work better for
certain application.
Nanorod stability in the in-vivo environment
In the potential in-vivo study, before the NRs arriving at the targeted site or even
during the incubation will cells, we need to ensure that they will not aggregate in the
physiological environments. Systematic study on the NR stability in the physiological
environments is a must prior to further in-vivo investigation. Long-term stability may be
achieved by sophisticated NR surface customization. Our preliminary study indicates that
neutral charged NRs is very stable in protein-rich media (Figure 9.1). Figure 9.1 shows
the absorption scan of different charged NRs incubated in 1x TBE (control) and albumin-
rich media at room temperature for lhr and 37 0C for 22hr. The disappearance
(broadening) of the NRs' absorption peak is due to their aggregation. The neutral charged
NR seems to be stable (not aggregate) for a long period of time (22hr) and even at high
temperature of 370C. Alternatively, we may also need to design microscale carriers for
delivering these NRs onto the targeted sites or even improving the cellular uptake.
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Figure 9.1. Gold nanorods stability in albumin-containing media. Absorption spectra of
(a) positively charged nanorods (NR-CTAB), (b) negatively charged nanorods (NR-
MHA), (c) neutral charged nanorods (NR-PEGs000) after lhr incubation at room
temperature, and (d) neutral charged nanorods (NR-PEGsooo) after 22 hr incubation at
370C in lx TBE (dash line) and albumin-containing media (solid line).
In-vivo selective release
Once we understand some of the fundamental concepts mentioned above, we can
then perform the in-vivo study to investigate selectivity of our controlled released
method. We can also learn whether our method can improve the efficacy of combination
therapy treatments; the very problem that motivated our thesis work. Comparing with
other methods8,' 21-23 is also a must for benchmarking the practicality of our method.
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Appendix A
TEM Images for Lipid-
Nanoparticle System
Below are additional high resolution TEM images; supporting figures for chapter 3.
Figure A.1. High resolution of Figure 3.3. (b) features perforated bicelles/lamellar phase.
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Figure A.2. High resolution of Figure 3.3. (c) feature perforated bicelles/lamellar phase
with NP-loaded vesicles
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Figure A.3. High resolution of Figure 3.3. (d) feature empty and NP-loaded vesicles
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Figure A.4. High resolution of Figure 3.3.
l*F 500 nm
(e) feature mostly HNLVs
130
Figure A.5. High resolution of Figure 3.3. (f) feature mostly LNLVs
131
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Figure A.6. High resolution TEM image of "bubble wrap" like lamellar phase.
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Figure A.7. High resolution TEM image of Figure 3.5. (a)
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Figure A.8. More TEM images of the same purified HNLV solution as in Figure 3.5. (a);
also used for size distribution analysis in Figure 3.5. (b).
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Figure A.9. More TEM images of the same purified HNLV solution as in Figure 3.5. (a);
also used for size distribution analysis in Figure 3.5. (b).
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Appendix B
Supporting Figures for
Gold Nanorod Ligand
Customization
Below are supporting figures for chapter 7.
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Figure B.1. TEM image and size analyses of (a) NR-MHDA and (b) NR-MUDA.
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Figure B.2. TEM image and size analyses of (a) NR-PEG 356, (b) NR-PEGooo, and (c)
NR-PEG 5000 .
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Figure B.3. FTIR spectra of (a) MHDA (black) and NR-MHDA (red), (b) MUDA
(black) and NR-MUDA (red), (c) PEG356 (black) and NR-PEG 356 (red), (d) PEGlooo(black) and NR-PEGlooo (red), and (e) PEGsooo (black) and NR-PEGsooo (red),
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Appendix C
Control Experiments for
Selective Release Study
Below are supporting figures for Chapter 8.
The graph below shows the fluorescence spectroscopy scans of supematants from
the mixture of both types of DNA-gold nanorods after 800nm laser irradiation at 1.41
mJ/cm2, one with the centrifugation (to remove the nanorods) performed immediately
after the irradiation (black line) and the other was 3 months after (red line). We observed
minimal re-adsorption of the released DNA back onto the melted gold NRs.
900-
Centrifuge immediately
750 -- Centrifuge after 3 months
600
rb
("450
S300
150-
01
500 520 540 560 580 600
Wavelength (nm)
Figure C.1. Re-adsorption of the DNA after laser irradiation.
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Figure C.2. (a) below shows the fluorescence scans of FAM-DNA (solid line)
and TMR-DNA (dash line) before (black line) and after (blue line) 800 nm laser
irradiation at 0.35mJ/cm 2 for 60 s. Figure C.2. (b) below shows the fluorescence scans of
FAM-DNA (solid line) and TMR-DNA (dash line) before (black line) and after (red line)
1100 nm laser irradiation at 1.73mJ/cm for 60 s. These show that laser irradiation has
minimal or no effect on the fluorophores.
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Figure C.2. Effect of (a) 800nm and (b) 1100nm laser irradiation on the fluorescence of
FAM and TMR.
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